rfhg_217061.1

Basic information about the TSS

---

TSS ID: rfhg_217061.1 TSS ID(Version3): hg_185979.1 hg_185977.1 hg_185976.1 hg_185978.1 Species: human Chr: chr20		Start: 543700 End: 543824 Strand: -
Source datasets	FANTOM5|PRJDB5282|PRJNA401781|PRJNA615891|PRJNA548673 |PRJNA597322|PRJNA4843412|DRA013844
Protocol	CAGE|C1CAGE|oligo_capping|RAMPAGE|SLIC_CAGE|ReCappable-seq |STRIPE-seq|NETCAGE
TSS cluster detected*	11

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D3268783,EH38E2091509)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000217244.9:0 ENST00000643660.1:0 ENST00000645623.1:0 ENST00000349736.10:0 ENST00000643700.1:0 ENST00000644170.1:0 ENST00000645910.1:0 ENST00000645840.1:0 ENST00000646305.1:0 ENST00000645260.1:0 ENST00000642689.1:0 ENST00000645234.1:0 ENST00000646814.1:0 ENST00000644885.1:0 ENST00000646477.1:0 ENST00000644710.1:0 ENST00000647155.1:0 ENST00000644003.1:0 ENST00000645249.1:0 ENST00000647026.1:0 ENST00000400217.7:0 ENST00000647348.1:0 ENST00000643600.1:0 ENST00000643680.1:0 ENST00000460062.7:0 ENST00000643968.1:0 ENST00000644177.1:0 ENST00000609525.2:0 ENST00000645091.1:0 ENST00000609606.6:0 ENST00000608066.6:0 ENST00000645187.1:0 ENST00000642160.1:0 ENST00000608490.2:0 BC050036:0 M55265:0 J02853:0 S53149:0 AK302583:0 BC002615:0 BC011668:0 AK312535:0 AY735339:0 GeneID: 1457 HGNC/MGI_ID: HGNC:2457 UniProt_ID: A0A2R8Y4D6 A0A2R8Y4H0 A0A2R8Y5A0 A0A2R8Y797 A0A2R8Y7T1 A0A2R8YCK2 A0A2R8YD58 A0A2R8YDP2 A0A2R8YDY7 A0A2R8YEL7 A0A2R8YEW1 A0A2R8YF43 A0A2R8YF47 A0A2R8YFU2 B2R6D7 P68400 Q5U5J2 V9GY80 V9GYA2 V9GYW6 Nearer transcript ids and distances: ENST00000400227.8:4 DQ354583:4 ENST00000646561.1:-11 ENST00000643910.1:461 view more...

Gene_name: casein kinase 2 alpha 1 Gene_symbol: CSNK2A1 Gene_synonyms: Cka1 Cka2 Gene_source: HGNC:2457

TATA-Box annotation

---

Distance to TSS:	28
Nearest PromoterID:	NM_001895
Entrez ID:	1457
Nearest Unigene:	Hs.644056
Nearest Refseq:	NM_001895
Nearest Ensembl:	ENSG00000101266
Gene Name:	casein kinase 2 alpha 1
Gene Alias:	CK2A1|CKII|Cka1|Cka2|OCNDS
Gene Type:	protein-coding
CpG%:	0.088710
GC%:	0.688000
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@CSNK2A1 p2@CSNK2A1 p3@CSNK2A1 p4@CSNK2A1
Sample		p1@CSNK2A1	p2@CSNK2A1	p3@CSNK2A1	p4@CSNK2A1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	55.52	20.65	4.68	0.19
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	57.86	15.38	2.83	0.81
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	60.96	23.53	4.05	0.19
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	45.12	17.88	2.49	0.21
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	52.64	20.70	2.02	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	54.27	22.29	4.26	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	81.71	26.80	6.10	0.00
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	66.85	23.98	5.09	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	61.34	13.68	4.92	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	41.73	22.03	2.90	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	54.98	19.81	4.85	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	49.19	15.45	3.66	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	14.51	15.47	0.81	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	10.22	17.74	0.90	0.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	11.64	16.69	0.88	0.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	12.07	14.59	1.01	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	10.27	13.10	0.87	1.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	7.59	17.29	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	9.06	14.40	0.00	1.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	13.24	14.59	1.20	0.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	11.49	16.04	0.53	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	9.84	17.95	0.35	0.86
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	12.15	15.77	0.78	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	7.52	11.41	0.73	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	9.03	17.03	0.52	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	10.13	18.36	1.27	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	8.79	10.44	0.55	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	9.67	14.38	0.71	1.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	8.24	13.08	0.48	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	11.04	12.67	0.72	0.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	7.96	12.35	1.05	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	10.16	13.29	0.00	0.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	6.33	17.52	0.42	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	9.07	18.64	0.16	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	9.35	12.53	1.31	0.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	6.71	12.46	0.96	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	9.40	11.85	0.61	1.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	6.25	13.70	0.40	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	11.07	18.64	1.08	1.08
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	7.92	12.72	0.24	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	6.12	11.29	0.94	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	6.88	12.74	0.59	0.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	6.54	11.18	0.84	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	7.87	15.38	0.17	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	6.22	18.07	1.00	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	4.89	13.73	0.23	0.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	4.08	13.19	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	8.64	12.52	0.60	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	9.34	7.90	0.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	6.27	11.12	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	8.81	11.27	1.02	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	10.90	14.45	0.89	0.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	27.98	69.96	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	11.00	15.97	0.71	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	9.28	12.59	0.33	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	15.10	44.46	0.84	3.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	8.73	14.70	0.92	1.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	12.96	14.58	0.65	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	11.24	10.92	0.96	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	9.12	19.17	0.00	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	13.40	17.63	0.00	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	13.46	16.26	2.80	2.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	9.55	24.68	0.00	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	8.15	13.25	0.68	0.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	14.62	15.60	1.30	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	15.62	12.78	1.06	1.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	48.49	48.49	16.16	16.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	55.28	150.05	0.00	7.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	19.50	20.96	1.95	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	20.33	22.31	2.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	17.36	15.95	0.94	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	24.84	21.53	0.66	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	33.10	21.04	3.71	0.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	35.77	19.26	3.36	0.92
Adipocyte - breast, donor1	11376-118A8	14.73	16.47	0.79	0.32
Adipocyte - breast, donor2	11327-117E4	11.87	14.28	0.64	0.16
Adipocyte - omental, donor1	11473-119C6	15.27	19.08	0.76	0.13
Adipocyte - omental, donor2	11474-119C7	7.47	11.21	1.49	0.75
Adipocyte - omental, donor3	11475-119C8	7.03	9.71	0.33	0.33
Adipocyte - perirenal, donor1	11476-119C9	14.04	7.02	0.00	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	4.40	4.40	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	15.81	17.16	0.90	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	9.56	12.34	1.04	0.17
Adipocyte differentiation, day04, donor1	13019-139D4	21.32	16.23	1.56	0.39
Adipocyte differentiation, day04, donor2	13022-139D7	9.52	9.52	0.51	0.77
Adipocyte differentiation, day04, donor3	13025-139E1	15.33	13.66	1.67	0.28
Adipocyte differentiation, day04, donor4	13028-139E4	8.23	15.28	0.00	1.18
Adipocyte differentiation, day08, donor1	13020-139D5	16.41	21.56	0.80	0.40
Adipocyte differentiation, day08, donor2	13023-139D8	7.10	19.69	0.32	0.65
Adipocyte differentiation, day08, donor3	13026-139E2	7.46	8.00	1.60	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	7.23	11.69	0.56	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	10.40	14.14	0.83	1.25
Adipocyte differentiation, day12, donor2	13024-139D9	6.53	11.30	0.75	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	9.49	12.44	0.65	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	8.22	9.74	1.22	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	40.00	21.22	5.30	1.55
Alveolar Epithelial Cells, donor2	11590-120G6	10.40	5.02	0.72	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	21.56	2.40	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	27.53	15.47	1.44	0.72
Amniotic Epithelial Cells, donor2	11613-122A2	5.02	11.71	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	19.11	14.18	1.64	0.21
Anulus Pulposus Cell, donor1	11248-116E6	28.15	21.28	1.37	0.46
Anulus Pulposus Cell, donor2	11463-119B5	12.74	14.20	0.73	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	12.13	16.17	0.90	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	8.68	16.93	0.43	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	19.26	8.56	2.14	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	13.45	17.64	0.60	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	12.65	15.18	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	12.54	11.22	1.32	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	15.92	14.29	0.32	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	11.17	11.65	1.46	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	20.19	12.47	0.59	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	11.68	22.22	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	9.43	18.14	2.18	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	15.05	8.78	1.25	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	21.25	16.64	1.32	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	19.11	13.65	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	15.53	15.08	0.90	0.75
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	10.72	13.39	0.00	0.54
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	13.60	15.30	0.94	0.19
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	13.90	16.30	1.07	0.80
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	4.88	16.58	2.93	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	14.60	15.42	0.83	1.16
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	18.01	16.81	1.20	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	14.16	14.16	3.54	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	13.38	16.47	0.34	0.34
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	12.58	25.17	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	9.71	15.05	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	19.35	15.94	1.52	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	8.48	10.90	1.21	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	11.40	18.24	1.14	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	13.25	11.97	0.43	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	12.13	12.65	0.77	0.52
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	15.01	11.26	0.00	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	14.47	15.76	0.32	0.64
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	17.12	14.27	0.00	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	9.94	12.87	0.58	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	18.37	15.35	1.20	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	23.76	13.07	1.19	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	14.24	13.22	1.02	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	14.77	17.32	0.76	0.76
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	13.34	18.43	1.27	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	9.49	11.22	2.16	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	12.70	15.45	1.06	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	17.40	11.60	0.87	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	16.06	12.28	2.83	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	14.58	14.58	1.19	0.17
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	9.27	4.63	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	10.56	19.01	2.11	2.11
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	12.22	16.51	0.64	0.86
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	13.84	16.85	0.60	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	16.77	13.85	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	16.78	18.16	0.00	0.69
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	15.30	7.65	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	19.32	17.54	1.53	0.51
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	12.39	11.56	2.06	0.41
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	15.91	10.71	1.22	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	8.60	20.55	1.43	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	13.97	15.52	2.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	10.68	6.10	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	9.42	13.85	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	15.89	15.89	0.79	0.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	14.17	13.08	1.09	0.36
Astrocyte - cerebellum, donor1	11500-119F6	31.69	24.44	1.47	0.61
Astrocyte - cerebellum, donor2	11580-120F5	22.59	13.86	0.86	0.17
Astrocyte - cerebellum, donor3	11661-122F5	11.12	9.86	1.26	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	34.51	26.14	2.44	1.74
Astrocyte - cerebral cortex, donor2	11316-117D2	34.78	25.24	3.24	1.29
Astrocyte - cerebral cortex, donor3	11392-118C6	30.28	20.43	2.98	1.34
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	64.80	47.82	4.13	1.03
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	60.51	45.60	5.01	0.63
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	64.64	50.87	4.89	1.25
Basophils, donor1	12241-129G9	8.11	11.51	0.26	0.26
Basophils, donor2	12242-129H1	8.66	23.45	0.36	0.00
Basophils, donor3	12243-129H2	11.91	13.82	1.18	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	37.30	13.15	1.94	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	15.09	3.20	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	50.21	14.35	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	32.01	3.77	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	39.30	9.98	2.50	0.42
Bronchial Epithelial Cell, donor6	11461-119B3	81.06	17.73	2.99	0.69
Bronchial Epithelial Cell, donor7	11769-123I5	34.37	17.99	1.44	0.18
Burkitt's lymphoma cell line:DAUDI	10422-106C8	40.19	38.23	1.96	0.93
Burkitt's lymphoma cell line:RAJI	10476-106I8	82.68	39.36	6.29	0.70
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	14.39	29.10	1.28	1.92
CD133+ stem cells - cord blood derived, pool1	12223-129E9	31.03	31.03	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	5.64	11.83	1.13	1.13
CD14+ Monocytes, donor2	11305-117B9	6.12	10.39	0.93	0.37
CD14+ Monocytes, donor3	11381-118B4	6.81	11.42	0.44	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	15.28	18.40	0.85	0.85
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	20.47	16.68	1.52	0.76
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	21.37	21.04	0.99	0.66
CD14+ monocytes - mock treated, donor1	11863-125A9	5.49	13.88	0.29	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	4.53	12.67	0.30	0.60
CD14+ monocytes - mock treated, donor3	11883-125D2	4.74	19.43	0.00	0.24
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	5.19	8.20	0.33	0.17
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	3.86	11.04	0.00	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	5.21	10.17	0.25	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	4.11	6.46	0.20	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	5.88	11.04	0.00	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	5.66	10.01	0.87	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	2.58	7.26	0.00	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	8.98	8.98	0.53	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	4.44	8.87	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	4.31	9.22	0.15	0.15
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	4.39	10.58	0.40	0.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	4.37	15.41	0.42	0.42
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	2.75	5.95	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	2.94	8.82	0.00	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	2.18	6.98	0.00	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	4.03	11.84	0.00	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	5.58	10.47	0.17	0.35
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	5.47	11.78	0.42	0.84
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	1.65	6.80	0.00	0.18
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	2.82	5.64	0.00	0.35
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	4.39	8.77	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	3.49	5.75	0.35	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	3.72	7.43	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	4.74	13.80	0.65	0.22
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	7.37	7.37	0.82	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	4.64	6.26	0.23	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	4.18	7.42	0.23	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	14.17	22.89	0.87	0.44
CD14+CD16+ Monocytes, donor2	11801-124D1	18.48	25.64	0.23	0.23
CD14+CD16+ Monocytes, donor3	11912-125G4	12.78	17.76	0.65	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	15.57	25.07	0.62	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	11.35	17.81	0.17	0.35
CD14+CD16- Monocytes, donor3	11910-125G2	22.97	31.66	0.89	0.45
CD14-CD16+ Monocytes, donor1	11790-124B8	16.84	16.33	1.28	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	16.69	27.23	1.10	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	20.00	24.84	0.84	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	16.26	34.55	0.00	2.03
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	18.31	27.80	0.00	0.68
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	12.43	37.28	0.00	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	12.79	29.32	0.53	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	13.40	44.49	1.07	1.07
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	14.74	28.78	1.40	0.70
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	17.26	29.81	0.78	2.35
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	21.09	39.55	0.00	1.32
CD19+ B Cells, donor1	11544-120B5	9.86	32.88	0.82	0.00
CD19+ B Cells, donor2	11624-122B4	7.25	20.31	0.73	0.00
CD19+ B Cells, donor3	11705-123B4	6.56	18.17	0.00	0.50
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	80.81	56.97	4.44	2.42
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	50.34	34.36	3.60	0.40
CD34+ Progenitors, donor1	11545-120B6	8.03	14.06	0.00	1.00
CD34+ Progenitors, donor2	11625-122B5	7.30	17.98	0.56	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	18.41	32.31	0.00	1.50
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	23.22	36.30	1.13	2.03
CD4+ T Cells, donor1	11225-116C1	11.43	25.71	0.36	1.07
CD4+ T Cells, donor2	11306-117C1	9.19	16.53	0.61	0.61
CD4+ T Cells, donor3	11382-118B5	7.32	18.30	0.61	0.61
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	18.38	37.26	0.77	0.51
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	14.60	37.73	0.67	0.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	16.67	29.32	0.29	0.29
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	12.33	25.13	0.95	0.47
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	16.15	24.58	0.00	0.70
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	16.48	32.96	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	13.01	26.88	0.87	0.43
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	14.40	27.62	0.68	0.34
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	16.28	25.79	0.97	0.48
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	11.66	21.52	1.34	0.45
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	10.13	25.16	0.70	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	14.08	34.32	0.88	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	10.54	37.95	0.84	0.84
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	14.75	17.45	0.42	0.62
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	14.37	22.39	0.00	0.67
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	13.87	32.36	0.82	0.27
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	15.54	28.94	0.00	1.07
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	7.17	28.69	1.79	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	19.66	36.34	0.56	0.56
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	9.96	30.11	0.43	0.87
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	13.66	24.59	0.42	1.47
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	10.62	19.72	0.00	0.51
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	7.37	19.50	0.00	0.43
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	10.90	30.94	0.87	0.44
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	16.83	35.14	0.99	0.49
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	18.46	21.23	0.92	2.77
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	20.94	18.15	1.40	2.79
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	16.06	36.28	0.00	1.38
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	20.12	41.96	0.98	0.74
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	16.94	29.26	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	20.41	33.30	0.72	1.07
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	15.23	26.31	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	8.51	23.90	0.98	0.33
CD8+ T Cells, donor2	11307-117C2	6.76	18.77	0.00	0.00
CD8+ T Cells, donor3	11383-118B6	10.10	23.23	0.50	0.25
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	23.17	15.14	1.84	0.46
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	27.08	12.46	2.64	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	26.26	22.43	2.19	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	33.62	29.12	3.60	0.60
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	24.48	19.92	2.64	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	25.47	19.33	1.82	0.23
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	28.46	23.25	1.96	0.43
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	30.27	18.16	1.05	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	27.20	17.59	1.88	0.23
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	35.62	24.15	4.23	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	24.98	18.59	3.78	0.58
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	28.51	21.58	2.66	0.80
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	30.64	11.82	0.44	0.88
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	22.77	11.39	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	31.33	11.93	1.49	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	25.93	16.93	1.44	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	26.18	12.37	1.73	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	25.22	13.20	1.89	0.24
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	32.96	25.99	3.17	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	33.83	18.15	3.38	0.31
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	28.21	15.39	2.24	0.64
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	32.89	20.65	2.68	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	32.32	22.07	3.94	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	26.47	10.59	4.54	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	36.94	20.07	1.61	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	36.37	21.68	1.40	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	37.06	9.02	4.01	0.00
Cardiac Myocyte, donor1	11525-119I4	5.48	16.45	1.83	0.00
Cardiac Myocyte, donor2	11605-120I3	25.20	8.89	1.48	0.00
Cardiac Myocyte, donor3	11686-122I3	24.52	26.41	1.37	1.16
Chondrocyte - de diff, donor1	11261-116G1	15.25	14.21	1.04	0.00
Chondrocyte - de diff, donor2	11338-117F6	7.11	15.64	0.71	0.00
Chondrocyte - de diff, donor3	11410-118E6	6.60	13.31	0.57	0.34
Chondrocyte - re diff, donor2	11339-117F7	29.54	42.97	1.79	0.00
Chondrocyte - re diff, donor3	11411-118E7	12.54	13.35	0.40	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	32.94	27.20	1.84	0.92
Ciliary Epithelial Cells, donor2	11323-117D9	19.88	18.17	2.78	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	25.93	22.04	2.65	0.97
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	31.82	45.02	1.83	1.56
Corneal Epithelial Cells, donor1	11526-119I5	32.50	6.59	2.20	0.66
Corneal Epithelial Cells, donor2	11606-120I4	32.99	10.24	2.28	0.00
Corneal Epithelial Cells, donor3	11687-122I4	43.20	7.92	2.81	0.51
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	32.85	20.97	2.48	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	33.12	19.56	1.26	0.63
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	31.06	10.35	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	23.33	16.41	0.76	0.86
Dendritic Cells - plasmacytoid, donor1	11228-116C4	7.17	26.31	0.34	0.34
Dendritic Cells - plasmacytoid, donor2	11309-117C4	7.83	26.11	0.00	0.65
Dendritic Cells - plasmacytoid, donor3	11385-118B8	6.78	23.71	0.48	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	34.52	23.85	0.83	1.00
Endothelial Cells - Aortic, donor1	11263-116G3	18.19	12.91	1.76	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	24.60	23.75	1.13	0.28
Endothelial Cells - Aortic, donor3	11412-118E8	39.32	25.56	3.93	0.00
Endothelial Cells - Artery, donor1	11264-116G4	17.45	20.65	1.16	1.16
Endothelial Cells - Artery, donor2	11341-117F9	26.59	27.76	1.18	0.47
Endothelial Cells - Artery, donor3	11413-118E9	25.95	26.65	0.88	0.70
Endothelial Cells - Lymphatic, donor1	11236-116D3	23.50	25.71	1.55	0.66
Endothelial Cells - Lymphatic, donor2	11317-117D3	24.34	27.99	0.91	0.61
Endothelial Cells - Lymphatic, donor3	11393-118C7	23.12	30.45	0.28	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	20.50	21.99	0.59	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	28.12	17.70	1.56	0.52
Endothelial Cells - Microvascular, donor3	11414-118F1	9.50	18.57	0.43	0.14
Endothelial Cells - Thoracic, donor1	11266-116G6	33.21	49.21	0.80	0.80
Endothelial Cells - Thoracic, donor2	11343-117G2	19.39	20.44	1.05	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	58.77	39.39	2.98	1.24
Endothelial Cells - Umbilical vein, donor2	11324-117E1	35.41	19.99	2.17	0.65
Endothelial Cells - Umbilical vein, donor3	11400-118D5	40.79	23.33	2.44	0.85
Endothelial Cells - Vein, donor1	11267-116G7	25.03	21.61	2.28	0.00
Endothelial Cells - Vein, donor2	11344-117G3	23.75	21.65	0.70	0.00
Endothelial Cells - Vein, donor3	11416-118F3	28.42	21.04	0.79	0.63
Eosinophils, donor1	12244-129H3	0.00	15.25	0.00	0.00
Eosinophils, donor2	12245-129H4	13.20	19.80	0.00	0.00
Eosinophils, donor3	12246-129H5	0.00	7.13	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	39.09	8.06	3.18	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	14.56	6.24	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	12.32	19.29	1.23	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	13.14	10.73	0.66	0.11
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	22.32	16.58	2.17	0.65
Fibroblast - Aortic Adventitial, donor1	11245-116E3	32.26	29.23	1.70	0.49
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	32.48	29.20	1.91	0.55
Fibroblast - Aortic Adventitial, donor2	11326-117E3	17.30	16.77	0.74	0.53
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	22.66	23.98	1.84	0.79
Fibroblast - Aortic Adventitial, donor3	11401-118D6	27.24	16.61	3.65	0.00
Fibroblast - Cardiac, donor1	11268-116G8	17.69	24.50	0.45	0.00
Fibroblast - Cardiac, donor2	11345-117G4	15.16	18.95	0.76	0.00
Fibroblast - Cardiac, donor3	11417-118F4	11.83	15.93	0.95	0.79
Fibroblast - Cardiac, donor4	11452-119A3	27.58	28.19	2.12	0.61
Fibroblast - Cardiac, donor5	11456-119A7	30.84	21.70	2.16	0.38
Fibroblast - Cardiac, donor6	11460-119B2	29.41	21.37	1.67	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	19.70	24.12	0.67	1.07
Fibroblast - Choroid Plexus, donor2	11572-120E6	8.63	19.41	0.43	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	41.01	16.11	2.93	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	90.87	35.29	5.07	0.92
Fibroblast - Conjunctival, donor3	11692-122I9	14.93	22.73	1.19	0.51
Fibroblast - Dermal, donor1	11269-116G9	26.30	11.97	0.94	0.00
Fibroblast - Dermal, donor2	11346-117G5	41.51	21.23	6.13	0.00
Fibroblast - Dermal, donor3	11418-118F5	22.36	14.26	0.85	0.12
Fibroblast - Dermal, donor4	11450-119A1	62.17	21.82	3.96	0.79
Fibroblast - Dermal, donor5	11454-119A5	69.96	25.64	4.01	0.70
Fibroblast - Dermal, donor6	11458-119A9	66.43	23.23	2.92	0.81
Fibroblast - Gingival, donor1	11237-116D4	44.98	17.70	1.46	0.83
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	22.27	18.34	2.62	0.26
Fibroblast - Gingival, donor2	11318-117D4	38.22	18.45	3.95	1.05
Fibroblast - Gingival, donor3	11394-118C8	36.55	22.43	1.55	0.77
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	15.58	19.74	2.08	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	12.51	13.57	1.41	0.35
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	32.89	22.60	3.43	0.78
Fibroblast - Gingival, donor6 (control)	11922-125H5	27.72	22.58	3.79	0.54
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	16.23	10.59	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	27.64	19.30	2.49	0.29
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	26.32	19.77	2.05	0.55
Fibroblast - Gingival, donor8 (control)	11926-125H9	39.27	23.91	3.29	0.99
Fibroblast - Gingival, donor9 (control)	11927-125I1	8.51	18.34	0.73	0.44
Fibroblast - Lung, donor1	11270-116H1	23.11	10.87	1.36	1.36
Fibroblast - Lung, donor2	11347-117G6	32.83	31.34	7.46	0.00
Fibroblast - Lung, donor3	11419-118F6	27.65	16.25	2.95	0.63
Fibroblast - Lymphatic, donor1	11506-119G3	59.14	23.32	0.83	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	26.57	15.38	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	8.40	4.20	0.28	0.00
Fibroblast - Mammary, donor1	11540-120B1	73.07	34.10	6.09	0.00
Fibroblast - Mammary, donor2	11620-122A9	23.97	15.98	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	17.87	5.96	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	61.10	27.54	3.88	0.78
Fibroblast - Periodontal Ligament, donor2	11319-117D5	66.28	26.54	4.25	0.61
Fibroblast - Periodontal Ligament, donor3	11395-118C9	50.79	33.35	3.06	0.92
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	22.52	16.41	1.53	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	20.25	13.77	2.97	0.54
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	13.11	10.79	1.04	1.04
Fibroblast - Pulmonary Artery, donor1	11250-116E8	30.06	23.65	1.77	0.44
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	62.58	26.82	2.84	0.41
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	28.06	9.35	2.67	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	19.77	13.44	1.19	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	28.38	24.61	2.58	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	12.26	20.25	0.18	0.36
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	19.31	21.29	0.59	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	21.06	22.86	1.50	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	22.02	28.93	0.86	0.76
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	20.50	22.02	1.52	0.76
Fibroblast - skin normal, donor1	11553-120C5	17.72	19.69	1.15	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	34.09	27.27	2.61	0.60
Fibroblast - skin normal, donor2	11561-120D4	25.62	23.31	1.21	0.20
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	22.97	21.76	1.21	1.21
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	15.16	22.70	0.66	0.58
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	17.95	28.21	0.51	0.34
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	16.42	17.41	1.31	0.66
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	27.59	24.39	1.81	0.75
Fibroblast - skin walker warburg, donor1	11554-120C6	29.52	21.76	3.37	0.34
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	12.86	17.72	0.47	0.47
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	177.28	44.32	0.00	22.16
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	14.82	7.84	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	25.48	18.20	1.73	0.35
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	34.61	16.66	2.86	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	36.28	28.62	1.02	1.02
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	58.18	19.90	9.95	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	59.34	28.08	6.38	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	103.84	32.52	11.13	0.57
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	79.69	14.89	11.58	0.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	50.00	18.27	10.50	0.68
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	85.59	21.00	7.13	0.99
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	75.60	14.01	9.78	0.53
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	44.03	15.00	8.81	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	95.96	23.44	11.94	1.77
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	59.36	33.92	4.52	0.71
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	48.15	30.29	4.93	0.25
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	47.01	26.06	3.22	0.54
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	41.75	28.25	2.97	0.50
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	52.33	28.65	3.74	1.25
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	55.10	24.40	4.47	1.02
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	40.84	24.64	3.65	0.68
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	39.11	27.53	3.11	0.50
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	56.83	22.08	5.25	0.66
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	32.21	23.93	0.89	1.77
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	28.77	31.31	1.91	0.16
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	37.98	26.14	2.01	0.89
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	26.21	27.62	2.22	0.81
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	23.92	35.96	1.87	1.36
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	55.77	42.03	3.90	1.51
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	46.51	41.10	2.91	1.35
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	39.96	45.60	2.05	0.85
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	27.11	29.66	2.21	1.22
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	43.35	34.61	2.83	1.08
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	40.22	28.79	0.61	0.82
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	24.55	25.79	1.03	0.62
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	28.94	33.90	1.73	0.69
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	28.02	26.52	0.50	0.50
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	23.59	24.25	1.76	0.88
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	22.63	30.99	1.11	0.74
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	24.31	26.26	2.43	0.16
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	27.58	28.86	2.25	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	20.66	23.03	2.08	1.14
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	21.99	22.30	1.27	0.79
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	24.02	30.10	2.13	0.61
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	19.97	32.72	0.84	0.84
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	22.83	21.52	1.32	1.98
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	22.72	27.49	2.52	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	19.07	29.16	1.30	0.46
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	18.72	22.19	1.60	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	18.82	25.25	1.99	0.31
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	18.52	24.61	2.07	0.52
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	18.16	20.87	0.81	1.08
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	16.04	26.18	1.47	0.74
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	13.16	21.71	1.32	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	12.89	34.71	1.98	0.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	11.74	19.13	0.79	0.53
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	13.72	20.18	0.61	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	23.13	61.00	1.02	1.78
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	85.60	49.57	4.98	1.19
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	57.16	32.05	7.70	0.46
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	75.49	47.67	7.98	1.43
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	67.91	36.93	6.57	1.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	65.55	31.65	4.80	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	50.73	29.98	8.30	1.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	51.97	27.22	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	62.66	35.20	5.42	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	83.43	25.67	3.21	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	59.12	29.56	3.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	53.05	27.99	4.56	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	53.95	35.00	4.94	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	49.98	19.99	6.66	3.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	46.42	26.57	1.12	0.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	50.33	27.45	2.61	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	40.26	20.13	1.68	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	49.30	24.49	1.91	0.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	49.59	30.91	4.42	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	20.88	20.88	2.09	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	56.70	27.49	2.29	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	43.21	27.82	2.66	0.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	30.49	22.02	5.08	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	35.62	36.86	2.90	1.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	40.27	40.50	3.45	1.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	36.88	5.27	5.27	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	29.22	22.68	1.15	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	25.10	22.49	2.61	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	30.77	12.71	1.34	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	42.76	29.67	2.31	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	23.62	41.77	1.71	2.05
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	37.27	22.36	0.00	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	49.54	36.33	3.30	1.89
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	38.02	16.90	4.22	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	39.68	35.10	2.03	1.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	31.91	27.92	3.99	1.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	48.35	32.56	1.48	1.97
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	59.02	25.97	3.54	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	40.84	20.42	3.50	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	63.20	24.14	3.07	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	33.91	30.52	0.85	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	22.09	26.86	1.79	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	25.23	25.23	0.49	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	7.99	11.41	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	4.99	8.73	1.25	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	16.87	15.74	1.12	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	5.71	15.54	0.00	0.95
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	10.86	10.03	0.42	1.25
Hep-2 cells mock treated, biol_rep1	11898-125E8	21.47	21.82	2.20	0.00
Hep-2 cells mock treated, biol_rep2	11899-125E9	26.16	17.22	2.03	0.17
Hep-2 cells mock treated, biol_rep3	11900-125F1	23.43	16.61	2.05	0.68
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	23.17	16.72	2.08	0.33
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	24.71	18.27	1.93	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	29.28	17.87	3.44	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	19.55	16.94	1.37	0.25
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	21.79	14.92	2.40	0.34
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	17.94	11.85	2.88	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	28.54	13.99	0.56	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	28.56	10.82	0.87	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	15.86	15.86	2.64	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	26.81	16.23	1.41	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	8.72	7.27	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	22.38	18.36	0.70	0.87
Hepatocyte, donor1	11523-119I2	8.47	16.95	0.00	0.00
Hepatocyte, donor2	11603-120I1	15.08	15.08	1.08	1.08
Hepatocyte, donor3	11684-122I1	12.27	16.57	0.61	1.23
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	39.16	68.53	3.26	2.61
Intestinal epithelial cells (polarized), donor1	11246-116E4	32.16	43.70	0.52	1.92
Iris Pigment Epithelial Cells, donor1	11530-119I9	27.17	24.97	1.51	1.23
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	28.66	3.18	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	26.70	6.68	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	27.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	20.77	12.46	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	25.03	5.01	2.50	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	71.21	11.87	11.87	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	35.88	12.81	2.56	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	50.28	13.71	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	35.74	6.50	1.62	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	28.34	6.67	1.67	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	39.94	3.63	7.26	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	25.15	6.62	1.32	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	27.72	11.09	1.11	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	5.24	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	22.05	10.08	1.89	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	30.93	6.19	3.09	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	29.27	0.00	14.63	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	20.67	12.92	1.29	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	24.15	11.27	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	23.90	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	14.67	8.96	0.81	0.81
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	24.35	5.88	1.26	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	14.37	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	22.50	8.84	1.61	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	26.78	9.23	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	30.16	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	27.85	8.50	1.42	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	14.51	7.26	4.53	0.91
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	29.48	0.00	14.74	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	20.45	7.53	2.15	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	20.33	7.62	1.27	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	32.86	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	13.39	8.29	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	10.94	7.29	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	47.41	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	26.42	4.28	1.43	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	29.86	6.64	3.32	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	21.91	9.88	1.54	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	10.54	5.27	1.76	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	22.00	3.14	3.14	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	23.64	10.43	2.78	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	35.41	8.85	2.21	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	12.97	12.97	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	33.13	11.34	0.87	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	20.25	0.00	2.25	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	20.91	3.48	6.97	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	22.40	11.73	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	20.78	6.93	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	11.40	11.40	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	24.85	12.89	2.76	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	15.13	9.08	3.03	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	17.98	3.17	3.17	0.00
Keratinocyte - epidermal, donor1	11272-116H3	42.84	24.89	2.28	0.16
Keratinocyte - epidermal, donor2	11349-117G8	32.21	12.88	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	38.62	18.27	3.31	1.33
Keratinocyte - oral, donor1	11251-116E9	81.51	36.33	6.02	1.25
Keratocytes, donor1	11527-119I6	74.96	41.26	2.75	1.38
Keratocytes, donor2	11607-120I5	44.53	5.86	4.69	1.17
Keratocytes, donor3	11688-122I5	31.22	25.09	2.17	0.40
Krukenberg tumor cell line:HSKTC	10687-109F3	30.77	30.77	2.20	0.00
Lens Epithelial Cells, donor1	11529-119I8	15.10	16.18	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	22.95	35.29	1.61	1.50
Lens Epithelial Cells, donor3	11690-122I7	21.29	36.83	1.82	2.42
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	16.48	23.00	1.30	0.59
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	14.51	13.95	0.56	0.56
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	15.43	20.94	0.47	0.47
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	8.07	11.83	1.61	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	15.44	11.98	0.63	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	10.03	14.55	0.97	0.22
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	7.39	15.18	0.41	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	10.62	10.11	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	10.84	12.25	0.56	0.14
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	11.07	15.82	0.40	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	13.77	13.18	0.78	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	7.04	7.78	0.56	0.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	13.24	15.68	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	13.12	12.16	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	10.99	10.16	1.37	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	14.78	16.32	1.23	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	8.11	7.79	0.31	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	11.71	12.99	0.55	0.55
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	14.48	13.49	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	11.42	8.79	0.59	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	9.71	11.20	0.50	0.50
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	14.06	11.15	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	12.66	14.54	1.35	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	12.11	16.20	0.30	0.30
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	10.37	16.07	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	16.12	17.38	0.84	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	9.92	14.59	1.05	0.30
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	13.07	15.13	0.69	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	12.23	12.79	0.94	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	8.16	12.94	0.32	0.42
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	14.05	18.41	1.94	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	18.19	17.86	1.32	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	9.29	12.39	0.37	0.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	13.70	19.25	0.00	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	14.33	14.82	0.74	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	8.39	12.37	0.69	0.27
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	17.69	18.33	1.61	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	16.43	18.56	0.91	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	14.00	13.72	0.84	0.56
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	13.16	15.29	0.71	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	11.15	10.67	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	7.62	8.09	1.09	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	15.04	12.53	0.72	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	18.29	19.93	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	6.83	8.71	0.47	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	19.55	24.01	0.87	0.37
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	11.78	12.55	0.51	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	9.25	14.02	1.49	0.90
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	9.06	9.06	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	15.34	10.74	0.00	0.77
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	8.91	11.13	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	17.77	13.12	0.42	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	9.85	12.66	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	6.54	11.21	0.93	0.93
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	10.82	8.76	0.00	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	9.52	11.89	1.19	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	17.19	14.48	0.00	0.68
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	15.70	14.54	0.87	0.29
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	13.51	8.55	0.45	0.90
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	20.86	18.16	1.76	0.81
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	18.49	13.87	0.51	1.03
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	15.53	15.53	0.35	2.12
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	8.00	11.99	0.00	2.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	19.36	19.87	2.04	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	14.14	17.88	0.53	0.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	20.41	16.06	0.94	0.38
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	19.02	19.02	0.61	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	19.57	11.42	0.00	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	14.99	17.70	1.25	0.62
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	15.97	14.85	1.68	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	19.58	14.42	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	18.29	17.71	0.58	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	17.34	12.26	0.60	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	14.38	16.04	1.66	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	18.73	25.10	1.06	0.35
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	23.60	15.12	0.37	1.48
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	10.36	9.21	1.15	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	18.80	18.42	0.77	1.15
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	19.25	15.29	0.57	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	14.77	19.69	0.82	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	17.62	16.27	0.90	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	12.21	12.93	0.72	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	15.68	17.18	0.75	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	18.58	18.58	1.11	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	16.37	11.20	1.29	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	8.56	10.28	0.86	1.71
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	16.33	14.99	0.67	0.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	16.89	14.48	0.60	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	9.24	9.95	0.71	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	15.81	16.84	1.03	1.03
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	22.01	13.96	2.68	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	18.85	11.45	1.35	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	18.89	15.19	1.11	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	13.96	17.44	1.16	1.16
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	11.64	9.52	1.06	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	26.01	17.21	2.00	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	16.72	10.90	0.73	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	16.86	16.86	0.77	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	20.22	16.28	0.99	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	13.17	13.17	1.88	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	20.11	19.11	0.50	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	21.18	17.57	0.90	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	12.05	17.21	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	16.48	19.60	0.00	0.89
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	21.51	19.55	0.78	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	19.13	9.24	1.98	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	16.61	17.12	0.52	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	19.69	21.00	0.88	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	20.13	18.45	0.56	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	18.99	25.17	1.32	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	22.76	20.83	1.93	0.77
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	15.19	12.15	0.51	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	16.34	15.86	2.40	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	24.25	17.49	0.80	0.40
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	18.84	16.41	3.04	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	17.98	13.14	0.69	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	21.28	15.96	2.66	0.38
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	22.21	17.56	1.03	0.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	10.88	13.30	0.60	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	20.28	19.33	2.85	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	21.86	17.06	0.53	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	17.81	14.94	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	22.11	21.08	1.03	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	20.51	19.10	0.00	1.41
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	12.48	14.19	1.13	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	20.80	19.14	2.08	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	17.23	16.44	0.78	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	9.60	22.13	0.42	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	17.66	20.44	0.00	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	16.06	12.04	2.01	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	16.04	14.97	0.00	1.60
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	15.76	21.82	1.21	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	21.11	12.85	0.92	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	12.45	22.23	1.78	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	14.82	26.78	1.71	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	13.04	19.17	1.53	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	16.96	17.51	0.55	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	16.48	17.37	1.34	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	23.66	23.14	1.04	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	11.94	17.24	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	37.41	22.86	4.16	0.00
Macrophage - monocyte derived, donor1	11232-116C8	15.73	19.60	0.23	0.23
Macrophage - monocyte derived, donor2	11313-117C8	22.20	14.50	1.10	0.37
Macrophage - monocyte derived, donor3	11389-118C3	22.55	16.91	1.70	0.52
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	22.83	15.93	0.53	0.00
Mallassez-derived cells, donor2	11929-125I3	32.01	24.56	1.74	0.48
Mallassez-derived cells, donor3	11930-125I4	43.78	27.52	2.22	0.97
Mammary Epithelial Cell, donor1	11273-116H4	56.30	29.20	3.59	0.40
Mammary Epithelial Cell, donor2	11350-117G9	46.04	24.32	2.03	0.87
Mammary Epithelial Cell, donor3	11422-118F9	29.18	11.22	1.75	0.00
Mast cell - stimulated, donor1	11487-119E2	33.90	61.69	1.36	1.36
Mast cell, donor1	11563-120D6	13.84	23.03	0.65	0.54
Mast cell, donor2	11565-120D8	5.05	14.56	1.49	0.00
Mast cell, donor3	11566-120D9	10.36	21.39	0.45	0.23
Mast cell, donor4	11567-120E1	10.99	15.25	0.35	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	19.96	33.71	1.00	0.44
Mast cell, expanded and stimulated, donor8	11942-126A7	19.26	30.35	1.75	0.58
Mast cell, expanded, donor5	11939-126A4	13.88	17.21	0.34	0.34
Mast cell, expanded, donor8	11941-126A6	15.40	15.90	0.33	0.17
Melanocyte - dark, donor1	11502-119F8	19.20	26.67	0.99	1.09
Melanocyte - dark, donor2	11582-120F7	20.42	17.65	1.73	0.35
Melanocyte - dark, donor3	11663-122F7	24.20	26.51	1.67	1.23
Melanocyte - light, donor1	11274-116H5	22.57	11.75	1.18	0.47
Melanocyte - light, donor2	11351-117H1	11.60	8.87	0.68	0.00
Melanocyte - light, donor3	11423-118G1	19.95	7.81	2.60	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	13.85	18.53	0.62	0.21
Melanocyte, donor2 (MC+2)	12739-135I3	16.67	15.60	0.81	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	15.00	13.39	0.80	0.54
Meningeal Cells, donor1	11493-119E8	61.66	33.12	1.98	0.99
Meningeal Cells, donor2	11573-120E7	37.85	24.21	1.76	0.88
Meningeal Cells, donor3	11654-122E7	44.74	31.05	2.85	0.90
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	48.19	17.96	4.28	0.86
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	17.31	13.89	0.91	0.10
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	2.63	3.94	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	13.08	2.62	1.31	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	29.42	12.92	1.44	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	14.19	22.02	0.42	0.21
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	16.59	15.08	1.01	1.01
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	42.41	16.92	3.08	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	43.84	10.96	4.38	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	30.28	6.96	2.66	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	16.21	19.11	0.97	0.14
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	6.69	7.43	0.00	0.74
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	18.42	24.21	1.05	0.92
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	5.64	9.20	0.00	0.59
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	16.35	4.67	2.34	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	23.69	13.45	1.92	1.28
Mesenchymal stem cells - adipose, donor0	11217-116B2	44.66	21.98	4.25	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	19.70	25.64	0.63	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	39.91	11.61	2.90	0.73
Mesothelial Cells, donor1	11247-116E5	26.52	26.25	1.59	0.80
Mesothelial Cells, donor2	12156-128G5	25.02	14.51	1.00	0.50
Mesothelial Cells, donor3	11402-118D7	18.36	17.42	0.94	0.29
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	9.45	14.85	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	20.19	17.49	1.48	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	22.97	17.37	1.77	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	3.46	3.46	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	13.64	10.85	0.93	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	18.46	13.48	0.41	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	4.63	2.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	15.27	19.02	0.25	0.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	24.20	12.57	0.47	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	19.47	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	12.60	14.43	0.00	0.41
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	20.59	14.65	1.58	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	11.50	14.16	0.88	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	21.66	15.96	1.14	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	9.21	2.63	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	11.67	12.73	0.64	0.42
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	16.57	3.68	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	10.73	13.11	0.30	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	5.03	5.03	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	13.30	11.54	0.50	0.50
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	23.53	13.55	1.43	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	8.85	4.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	12.43	14.97	0.00	0.46
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	23.14	17.46	0.84	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	15.29	13.86	1.02	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	10.51	11.37	0.86	0.43
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	18.23	14.67	1.78	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	14.02	10.73	0.66	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	19.26	8.62	1.52	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	9.94	4.97	1.66	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	16.85	11.14	0.82	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	30.29	12.65	2.06	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	10.90	4.36	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	14.42	11.05	1.92	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	35.62	24.81	2.80	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	8.23	10.97	1.37	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	18.02	12.01	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	53.89	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	2.04	8.15	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	15.77	14.89	2.19	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	14.35	2.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	10.89	8.97	0.64	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	19.59	16.61	1.74	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	14.61	6.26	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	6.63	6.63	0.00	2.21
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	19.49	17.44	1.03	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	18.38	9.63	0.88	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	7.81	8.52	0.36	0.71
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	19.64	15.71	1.40	0.56
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	24.94	9.14	1.66	0.42
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	10.49	5.24	1.17	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	22.93	17.50	1.21	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	24.63	15.86	2.09	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	19.39	13.85	0.92	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	37.56	11.38	1.71	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	13.40	16.86	0.55	0.28
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	22.55	13.48	1.30	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	23.59	9.87	0.43	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	10.80	10.16	1.91	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	21.62	16.28	0.80	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	31.13	24.55	0.30	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	16.24	15.96	0.42	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	22.61	18.47	1.59	0.32
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	26.09	16.14	1.99	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	17.82	8.72	0.38	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	26.14	20.46	0.28	0.57
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	24.58	17.45	1.72	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	8.47	7.82	0.65	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	27.05	14.70	1.18	0.88
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	33.73	22.20	2.02	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	20.61	31.74	2.89	0.82
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	21.44	21.14	1.19	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	3.77	11.30	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	8.91	12.48	1.78	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	11.50	15.11	0.66	0.33
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	10.52	7.36	1.05	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	13.24	15.42	0.99	0.40
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	16.76	10.24	0.93	0.93
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	11.64	13.14	1.13	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	10.12	9.85	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	8.93	14.82	0.34	0.23
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	11.79	8.84	0.74	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	15.02	14.29	0.37	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	10.89	7.78	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	10.15	13.90	0.53	0.53
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	15.46	7.73	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	10.10	11.11	1.01	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	12.23	11.38	0.42	0.84
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	4.09	13.62	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	3.18	3.18	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	4.86	7.29	0.00	1.62
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	13.59	15.10	1.51	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	5.71	28.55	5.71	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	19.57	19.57	3.26	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	14.26	4.75	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	37.65	12.55	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	31.88	23.70	1.29	0.65
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	13.59	14.63	2.09	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	22.69	18.69	6.67	1.33
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	33.81	7.10	3.34	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	32.70	18.25	3.61	0.57
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	36.70	23.94	9.58	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	31.96	6.80	4.08	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	67.99	22.05	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	19.67	10.88	3.35	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	33.24	12.32	2.32	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	27.83	12.97	4.32	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	22.92	13.46	1.89	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	66.81	11.13	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	14.39	12.91	0.50	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	11.37	11.10	0.81	1.08
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	13.15	7.25	0.91	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	18.45	10.94	1.47	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	10.39	16.77	0.55	0.36
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	10.08	15.38	2.12	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	11.41	4.80	1.20	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	12.47	18.05	2.63	0.66
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	12.03	7.16	0.81	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	11.99	13.76	0.53	0.35
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	11.25	14.06	1.41	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	9.19	9.65	0.92	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	11.89	11.57	0.64	0.64
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	8.97	23.11	1.72	1.03
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	35.40	70.80	0.00	2.53
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	12.25	14.04	1.34	0.67
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	13.13	8.47	1.27	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	8.31	9.73	0.47	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	15.02	12.02	1.72	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	81.25	126.39	9.03	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	12.66	12.66	2.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	14.43	11.72	1.80	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	19.84	13.09	0.40	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	18.57	15.79	0.93	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	12.49	15.13	1.51	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	22.49	13.69	2.61	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	15.25	7.84	3.05	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	13.12	17.19	0.00	0.90
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	14.99	14.99	0.88	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	12.63	11.97	1.33	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	12.40	12.40	1.49	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	21.06	10.34	1.91	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	13.31	17.84	0.30	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	13.04	17.68	0.00	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	19.65	8.81	1.36	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	45.99	56.20	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	17.07	21.34	1.83	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	15.11	11.65	1.57	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	13.92	11.20	2.12	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	6.33	13.45	1.58	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	12.47	26.07	1.13	2.27
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	15.17	55.64	0.00	0.00
Myoblast, donor1	11241-116D8	29.32	17.89	2.11	0.25
Myoblast, donor2	11322-117D8	19.37	17.64	1.73	0.38
Myoblast, donor3	11398-118D3	25.39	22.03	1.18	0.67
NK T cell leukemia cell line:KHYG-1	10777-110G3	35.17	40.13	1.02	0.88
Natural Killer Cells, donor1	11230-116C6	11.07	23.37	0.31	0.31
Natural Killer Cells, donor2	11311-117C6	5.73	21.11	0.90	0.00
Natural Killer Cells, donor3	11387-118C1	8.28	20.25	0.37	0.37
Neural stem cells, donor1	11275-116H6	40.65	61.70	3.27	1.45
Neural stem cells, donor2	11352-117H2	78.95	73.17	3.85	1.93
Neurons, donor1	11494-119E9	20.48	45.52	0.00	2.28
Neurons, donor2	11574-120E8	35.67	57.68	1.10	0.88
Neurons, donor3	11655-122E8	23.84	50.15	0.82	3.29
Neutrophils, donor1	11233-116C9	8.35	16.70	0.93	0.00
Neutrophils, donor2	11314-117C9	5.80	11.60	0.00	0.00
Neutrophils, donor3	11390-118C4	17.71	13.44	0.00	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	15.55	29.21	1.42	1.31
Nucleus Pulposus Cell, donor2	11409-118E5	18.23	11.72	0.65	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	17.65	16.45	0.60	0.80
Olfactory epithelial cells, donor1	11933-125I7	12.39	13.63	0.83	0.00
Olfactory epithelial cells, donor2	11934-125I8	12.01	16.79	1.45	0.29
Olfactory epithelial cells, donor3	11935-125I9	15.10	13.62	1.82	0.11
Olfactory epithelial cells, donor4	11936-126A1	16.85	17.73	0.97	0.49
Oligodendrocyte - precursors, donor1	11496-119F2	43.33	34.91	2.41	0.60
Osteoblast - differentiated, donor1	11276-116H7	13.61	16.80	0.85	0.00
Osteoblast - differentiated, donor2	11353-117H3	8.00	2.29	1.14	0.00
Osteoblast - differentiated, donor3	11425-118G3	9.93	4.34	2.48	0.62
Osteoblast, donor1	11277-116H8	27.75	20.91	1.56	0.78
Osteoblast, donor2	11354-117H4	52.67	32.31	4.92	1.40
Osteoblast, donor3	11426-118G4	32.17	20.62	2.31	0.36
Pancreatic stromal cells, donor1	11249-116E7	25.27	18.19	1.94	0.59
Pericytes, donor1	11491-119E6	12.46	8.79	0.67	0.33
Pericytes, donor2	11571-120E5	10.19	10.87	0.91	0.91
Pericytes, donor3	11652-122E5	22.58	11.60	1.63	0.41
Perineurial Cells, donor1	11499-119F5	37.75	27.35	2.15	0.68
Perineurial Cells, donor2	11579-120F4	34.78	27.24	2.30	1.10
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	17.21	29.64	0.32	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	7.35	17.87	0.24	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	8.67	17.99	0.78	0.26
Placental Epithelial Cells, donor1	11278-116H9	16.98	10.04	1.20	0.00
Placental Epithelial Cells, donor2	11355-117H5	3.33	5.54	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	5.50	7.46	0.00	0.20
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	8.54	8.54	1.27	0.00
Preadipocyte - breast, donor1	11467-119B9	11.07	16.32	1.13	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	15.40	23.23	0.91	0.26
Preadipocyte - breast, donor2	11328-117E5	11.03	14.86	0.68	0.45
Preadipocyte - omental, donor1	11468-119C1	15.24	17.26	0.75	0.53
Preadipocyte - omental, donor2	11329-117E6	20.51	15.71	0.87	0.00
Preadipocyte - omental, donor3	11403-118D8	18.48	18.48	1.86	1.00
Preadipocyte - perirenal, donor1	11469-119C2	5.91	10.83	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	25.49	13.82	0.31	0.61
Preadipocyte - subcutaneous, donor2	11356-117H6	37.36	22.84	3.90	0.18
Preadipocyte - subcutaneous, donor3	11428-118G6	19.41	14.99	1.87	0.68
Preadipocyte - visceral, donor1	11280-116I2	45.83	26.64	2.42	0.65
Preadipocyte - visceral, donor2	11357-117H7	37.73	23.93	2.30	1.38
Preadipocyte - visceral, donor3	11429-118G7	18.70	15.88	1.88	0.84
Prostate Epithelial Cells (polarized), donor1	11253-116F2	37.11	46.92	2.11	2.26
Prostate Epithelial Cells, donor2	11331-117E8	30.60	10.02	2.57	0.14
Prostate Epithelial Cells, donor3	11404-118D9	92.41	28.29	7.04	0.67
Prostate Stromal Cells, donor1	11254-116F3	43.85	24.26	2.73	0.34
Prostate Stromal Cells, donor2	11332-117E9	33.35	19.01	3.05	0.18
Prostate Stromal Cells, donor3	11405-118E1	12.41	11.99	1.25	0.52
Renal Cortical Epithelial Cells, donor1	11516-119H4	46.72	16.06	1.82	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	58.57	23.29	4.51	0.55
Renal Epithelial Cells, donor1	11517-119H5	23.33	6.59	2.54	0.51
Renal Epithelial Cells, donor2	11597-120H4	32.72	9.96	0.71	0.00
Renal Epithelial Cells, donor3	11678-122H4	56.00	27.00	4.13	0.85
Renal Glomerular Endothelial Cells, donor1	11514-119H2	17.02	10.89	0.68	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	33.56	17.12	1.21	0.13
Renal Glomerular Endothelial Cells, donor3	11675-122H1	29.31	23.53	1.11	0.44
Renal Glomerular Endothelial Cells, donor4	11783-124B1	3.99	5.32	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	25.53	15.63	1.98	0.44
Renal Mesangial Cells, donor2	11598-120H5	33.86	10.03	2.51	0.00
Renal Mesangial Cells, donor3	11679-122H5	8.04	4.99	0.55	0.55
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	70.86	25.23	4.29	0.54
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	43.01	16.87	2.53	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	35.87	11.76	1.93	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	49.78	26.45	0.52	0.52
Retinal Pigment Epithelial Cells, donor1	11528-119I7	24.45	22.74	1.14	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	17.50	12.35	2.06	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	24.84	34.37	1.51	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	16.57	23.65	0.67	0.94
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	9.83	8.93	0.89	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	10.46	37.43	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	12.18	20.88	0.58	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	25.22	31.34	0.78	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	23.63	24.03	1.29	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	30.67	32.57	1.12	0.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	25.80	38.45	1.74	0.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	18.88	25.99	1.40	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	23.11	29.82	2.77	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	17.25	25.74	0.96	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	19.36	22.69	1.82	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	26.34	23.65	1.79	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	17.79	23.53	0.86	0.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	17.81	21.36	1.29	0.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	20.36	25.89	1.99	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	15.87	21.03	0.76	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	20.40	22.82	1.49	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	30.25	38.15	2.25	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	16.46	21.76	1.46	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	18.69	23.65	1.36	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	21.01	28.45	3.06	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	14.95	24.03	1.17	0.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	21.58	26.63	2.52	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	22.39	26.66	1.71	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	18.42	19.69	0.55	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	16.19	22.93	1.23	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	21.76	28.34	1.48	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	21.23	25.24	0.71	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	21.23	22.22	1.39	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	28.30	23.85	2.10	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	22.60	24.68	1.04	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	24.78	30.75	2.88	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	24.44	20.47	2.51	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	19.65	27.32	1.21	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	14.13	22.99	2.04	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	25.83	25.64	1.93	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	21.49	24.59	1.72	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	16.73	23.59	0.96	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	21.67	26.76	3.12	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	13.12	21.82	1.36	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	17.90	25.15	0.89	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	21.06	23.99	1.33	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	15.21	20.19	0.83	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	16.43	19.52	1.19	0.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	20.15	24.39	0.81	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	11.77	19.40	0.28	1.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	11.18	25.15	1.40	1.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	7.86	23.87	0.91	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	11.38	18.36	0.73	0.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	18.63	36.24	1.16	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	7.91	20.08	0.61	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	11.75	15.97	0.90	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	10.40	13.80	0.68	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	13.78	18.87	0.90	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	9.68	20.54	0.35	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	8.96	9.39	0.85	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	11.42	10.22	0.60	0.00
Schwann Cells, donor1	11498-119F4	27.27	9.03	2.07	0.19
Schwann Cells, donor2	11578-120F3	34.02	13.61	3.40	3.40
Schwann Cells, donor3	11659-122F3	19.94	18.18	1.97	1.53
Sebocyte, donor1	11220-116B5	58.06	29.58	3.83	0.55
Sebocyte, donor2	11301-117B5	30.33	13.33	3.22	0.46
Sebocyte, donor3	11378-118B1	23.29	11.13	1.65	0.82
Sertoli Cells, donor1	11255-116F4	38.10	24.85	1.66	1.66
Sertoli Cells, donor2	11333-117F1	16.95	16.95	2.82	0.00
Skeletal Muscle Cells, donor1	11281-116I3	37.57	42.93	2.55	0.70
Skeletal Muscle Cells, donor2	11358-117H8	8.67	10.12	2.17	0.00
Skeletal Muscle Cells, donor3	11430-118G8	33.44	20.90	1.67	0.84
Skeletal Muscle Cells, donor4	11451-119A2	41.63	15.87	2.04	1.10
Skeletal Muscle Cells, donor5	11455-119A6	44.89	17.69	2.53	0.59
Skeletal Muscle Cells, donor6	11459-119B1	54.48	19.39	4.92	0.46
Skeletal Muscle Satellite Cells, donor1	11240-116D7	48.26	25.33	3.65	1.01
Skeletal Muscle Satellite Cells, donor2	11321-117D7	36.10	15.98	2.28	0.71
Skeletal Muscle Satellite Cells, donor3	11397-118D2	53.87	21.53	4.66	0.79
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	28.31	38.00	2.27	0.42
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	33.29	20.99	1.45	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	13.07	11.01	1.38	0.69
Skin - palm, donor1	10286-104F7	13.43	2.69	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	27.97	7.78	2.31	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	64.61	26.17	2.45	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	26.35	10.65	1.95	0.26
Small Airway Epithelial Cells, donor1	11256-116F5	77.15	28.50	5.14	0.56
Small Airway Epithelial Cells, donor2	11334-117F2	31.51	18.14	2.11	0.56
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	50.11	30.24	5.71	2.11
Small Airway Epithelial Cells, donor3	11406-118E2	68.73	28.63	6.30	0.60
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	20.68	21.29	1.54	0.93
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	25.12	18.90	1.78	0.67
Smooth Muscle Cells - Aortic, donor0	11210-116A4	21.16	17.05	0.59	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	46.63	30.94	2.65	0.22
Smooth Muscle Cells - Aortic, donor2	11360-117I1	31.11	15.36	3.94	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	20.09	13.91	1.55	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	9.01	22.02	1.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	21.03	16.24	0.93	0.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	15.74	17.07	0.22	0.44
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	54.41	30.34	2.56	1.02
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	25.40	16.61	2.28	0.98
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	21.85	19.79	0.89	1.18
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	22.35	10.39	2.56	0.43
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	26.68	8.95	1.30	0.33
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	14.00	18.87	0.30	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	20.21	18.18	0.76	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	91.81	24.48	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	20.50	15.26	0.48	0.48
Smooth Muscle Cells - Colonic, donor1	11239-116D6	23.60	14.45	2.36	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	21.95	11.41	1.08	0.22
Smooth Muscle Cells - Colonic, donor3	11396-118D1	24.46	14.27	2.94	0.42
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	30.32	17.32	2.17	0.31
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	25.87	11.86	1.08	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	26.00	19.72	0.90	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	17.41	8.88	0.68	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	37.30	27.80	2.28	1.02
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	31.30	21.34	2.21	0.20
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	20.93	23.67	1.59	0.23
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	12.68	15.10	1.21	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	75.77	40.00	5.30	1.59
Smooth Muscle Cells - Prostate, donor1	11257-116F6	32.62	20.91	1.33	0.80
Smooth Muscle Cells - Prostate, donor2	11335-117F3	24.04	15.28	2.25	0.38
Smooth Muscle Cells - Prostate, donor3	11465-119B7	8.88	11.16	0.25	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	32.72	22.77	2.71	1.06
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	18.75	9.75	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	244.23	104.67	34.89	1.29
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	17.21	17.21	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	16.66	20.70	1.01	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	21.62	17.55	0.63	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	16.22	5.90	0.29	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	45.90	30.82	3.92	1.50
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	15.42	9.81	0.47	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	29.50	19.43	1.15	1.01
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	26.52	20.40	1.53	0.51
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	28.39	15.61	1.50	0.94
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	41.78	28.51	2.93	1.26
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	26.81	24.30	1.93	1.01
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	17.14	3.81	0.95	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	30.34	16.88	1.71	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	21.21	20.11	0.66	0.22
Smooth Muscle Cells - Uterine, donor3	11466-119B8	31.60	11.41	3.51	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	6.61	9.13	0.39	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	13.49	8.73	1.59	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	13.02	18.97	0.37	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	20.12	11.14	0.36	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	18.45	11.92	0.85	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	25.60	19.69	2.76	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	10.16	10.92	0.25	0.25
Smooth muscle cells - airway, control, donor2	11967-126D5	7.99	11.98	1.60	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	9.20	5.85	0.00	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	6.42	6.88	0.46	0.00
Synoviocyte, donor1	11291-117A4	13.13	16.33	1.01	0.00
Synoviocyte, donor2	11368-117I9	5.03	11.90	0.50	0.17
Synoviocyte, donor3	11440-118H9	6.03	10.50	0.45	0.45
Trabecular Meshwork Cells, donor1	11532-120A2	40.38	16.08	1.79	0.71
Trabecular Meshwork Cells, donor2	11612-122A1	27.75	5.95	1.98	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	17.37	8.34	1.16	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	75.91	20.65	4.59	0.36
Tracheal Epithelial Cells, donor2	11369-118A1	32.08	10.44	2.71	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	29.21	14.89	0.57	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	16.24	21.28	0.86	0.74
Urethra, donor2	10319-105A4	10.79	14.39	0.00	0.00
Urothelial Cells, donor1	11520-119H8	41.97	14.35	1.59	1.06
Urothelial Cells, donor2	11600-120H7	35.25	7.21	2.80	0.00
Urothelial Cells, donor3	11681-122H7	22.46	6.65	0.46	0.23
Urothelial cells, donor0	11216-116B1	67.54	28.75	3.12	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	30.25	22.24	1.78	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	32.88	34.31	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	21.90	17.11	0.00	0.68
Whole blood (ribopure), donor090325, donation1	12176-128I7	19.28	23.76	0.34	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	27.31	25.57	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	19.78	29.15	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	23.86	37.63	0.00	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	22.82	25.56	0.91	0.91
Wilms' tumor cell line:G-401	10809-111A8	55.02	25.66	6.41	0.86
Wilms' tumor cell line:HFWT	10597-108E3	48.40	11.44	6.16	1.76
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	66.20	16.48	5.87	0.56
achilles tendon, donor2	10292-104G4	45.46	14.47	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	38.75	35.44	2.80	2.29
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	49.22	55.03	3.48	0.93
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	39.17	38.94	2.97	1.31
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	73.20	54.15	5.17	2.72
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	57.62	46.10	5.62	1.12
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	24.95	35.32	0.21	0.63
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	53.08	45.73	3.54	1.09
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	52.00	33.05	1.76	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	24.09	38.39	1.23	0.82
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	33.78	43.49	3.49	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	44.90	30.54	2.94	0.37
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	35.10	11.70	11.70	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	52.29	53.22	3.72	1.63
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	54.37	43.50	3.11	0.52
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	49.68	42.67	2.92	0.29
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	23.70	15.34	1.39	0.93
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	18.51	27.14	2.47	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	26.09	9.82	2.76	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	27.74	23.04	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	29.42	22.75	1.52	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	30.33	25.51	2.17	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	70.39	41.87	4.01	0.22
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	58.37	30.02	5.67	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	107.78	29.73	11.15	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	86.26	45.95	4.90	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	32.27	34.02	0.87	0.87
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	33.74	26.24	1.87	0.00
adenocarcinoma cell line:IM95m	10796-110I4	39.09	34.15	2.35	0.47
adipose tissue, adult, pool1	10010-101C1	15.67	24.35	0.47	1.24
adipose, donor1	10184-103D4	73.89	27.56	7.04	2.35
adipose, donor2	10185-103D5	32.85	6.49	10.54	0.81
adipose, donor3	10186-103D6	49.01	14.70	6.81	0.54
adipose, donor4	10187-103D7	147.35	46.80	19.94	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	125.15	26.36	14.05	0.47
adrenal gland, adult, pool1	10081-102A9	3.64	32.74	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	45.09	13.07	3.34	0.27
alveolar cell carcinoma cell line:SW 1573	10708-109H6	65.39	35.73	5.00	0.71
amniotic membrane cells, donor1	12235-129G3	10.67	16.69	0.46	0.93
amniotic membrane cells, donor2	12236-129G4	25.70	21.98	1.01	1.01
amniotic membrane cells, donor3	12237-129G5	23.57	15.02	1.47	0.59
amygdala - adult, donor10196	10167-103B5	20.16	42.69	3.56	0.00
amygdala, adult, donor10252	10151-102I7	17.64	43.80	1.42	1.82
amygdala, newborn, donor10223	10360-105E9	22.92	24.85	3.23	0.65
anaplastic carcinoma cell line:8305C	10428-106D5	114.47	89.26	5.09	1.40
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	45.45	27.58	3.09	0.88
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	40.42	45.76	2.34	0.67
aorta, adult, pool1	10052-101G7	12.16	21.77	0.59	0.00
appendix, adult	10189-103D9	17.85	13.97	1.16	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	34.39	32.67	2.06	1.03
artery, adult	10190-103E1	23.10	19.02	1.36	0.00
astrocytoma cell line:TM-31	10425-106D2	27.96	44.18	1.16	1.16
b cell line:RPMI1788	10427-106D4	81.93	31.67	3.27	0.45
basal cell carcinoma cell line:TE 354.T	10702-109G9	20.81	23.03	1.94	1.39
bile duct carcinoma cell line:HuCCT1	10432-106D9	80.08	35.23	4.07	0.99
bile duct carcinoma cell line:TFK-1	10496-107C1	40.67	38.33	2.01	0.33
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	25.72	26.84	1.12	0.56
bladder, adult, pool1	10011-101C2	21.08	24.66	0.54	0.33
blood, adult, pool1	10053-101G8	26.58	19.93	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	11.13	10.28	0.00	0.00
bone marrow, adult	10192-103E3	18.22	26.32	0.00	0.00
brain, adult, donor1	10084-102B3	13.33	31.78	0.00	2.05
brain, adult, pool1	10012-101C3	19.93	29.40	1.00	1.22
brain, fetal, pool1	10085-102B4	26.71	40.07	2.67	0.00
breast carcinoma cell line:MCF7	10482-107A5	19.16	16.19	1.32	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	23.72	32.20	1.62	0.62
breast, adult, donor1	10080-102A8	21.47	15.78	1.26	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	97.44	44.34	12.07	0.89
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	27.83	38.03	1.86	1.86
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	27.17	12.20	1.84	0.46
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	15.74	8.47	1.21	0.00
carcinoid cell line:NCI-H1770	10703-109H1	101.09	9.87	2.35	0.47
carcinoid cell line:NCI-H727	10735-110B6	38.50	39.27	1.86	1.20
carcinoid cell line:SK-PN-DW	10719-109I8	73.52	20.60	6.97	0.63
carcinosarcoma cell line:JHUCS-1	10642-109A3	54.03	35.40	5.06	0.53
caudate nucleus - adult, donor10196	10177-103C6	20.72	31.09	2.30	1.15
caudate nucleus, adult, donor10252	10164-103B2	16.40	39.15	1.34	1.84
caudate nucleus, adult, donor10258	10379-105H1	19.87	22.92	1.53	0.00
caudate nucleus, newborn, donor10223	10354-105E3	25.64	29.66	1.10	0.37
cerebellum - adult, donor10196	10173-103C2	20.39	61.18	2.91	0.00
cerebellum, adult, donor10252	10166-103B4	23.06	70.03	0.64	1.07
cerebellum, adult, pool1	10083-102B2	15.87	29.32	2.07	0.34
cerebellum, newborn, donor10223	10357-105E6	20.76	64.76	2.49	0.83
cerebral meninges, adult	10188-103D8	15.88	23.20	1.26	0.50
cerebrospinal fluid, donor2	10294-104G6	19.00	9.50	0.73	0.00
cervical cancer cell line:D98-AH2	10552-107I3	80.37	38.39	4.03	0.29
cervical cancer cell line:ME-180	10553-107I4	28.67	34.30	1.33	0.83
cervix, adult, pool1	10013-101C4	15.12	28.56	0.73	0.73
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	45.15	52.25	3.07	0.56
chondrosarcoma cell line:SW 1353	10700-109G7	15.68	18.29	3.92	0.00
choriocarcinoma cell line:BeWo	10423-106C9	39.52	25.73	1.74	0.87
choriocarcinoma cell line:SCH	10785-110H2	44.23	25.01	3.20	0.74
choriocarcinoma cell line:T3M-3	10618-108G6	23.48	11.15	2.85	0.71
chorionic membrane cells, donor1	12238-129G6	6.27	16.53	0.85	0.57
chorionic membrane cells, donor2	12239-129G7	25.65	26.85	1.89	1.59
chorionic membrane cells, donor3	12240-129G8	9.34	24.73	0.00	1.10
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	23.23	21.21	2.02	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	46.10	36.11	2.31	0.38
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	38.22	26.40	3.38	1.06
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	59.83	17.72	3.60	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	68.21	21.77	4.84	0.24
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	61.29	24.03	3.87	0.81
chronic myelogenous leukemia cell line:K562	10454-106G4	107.48	40.93	7.07	0.29
chronic myelogenous leukemia cell line:KU812	10409-106B4	106.07	63.85	7.56	2.35
clear cell carcinoma cell line:JHOC-5	10638-108I8	117.26	47.32	9.83	0.91
clear cell carcinoma cell line:TEN	10636-108I6	30.71	16.83	1.39	0.00
colon carcinoma cell line:CACO-2	10513-107D9	44.30	34.05	2.93	1.46
colon carcinoma cell line:COLO-320	10420-106C6	115.16	66.13	7.60	1.14
colon, adult, donor1	10082-102B1	23.80	23.80	2.38	2.38
colon, adult, pool1	10014-101C5	18.92	25.38	0.82	0.82
colon, fetal, donor1	10070-101I7	29.05	35.23	1.24	0.62
common myeloid progenitor CMP, donor1	12130-128D6	22.92	27.50	0.00	4.58
common myeloid progenitor CMP, donor2	12134-128E1	0.00	25.04	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	64.59	29.32	5.95	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	40.15	23.24	3.62	0.45
cord blood derived cell line:COBL-a untreated	10449-106F8	42.02	35.39	3.67	0.85
corpus callosum, adult, pool1	10042-101F6	23.11	57.16	1.44	1.66
cruciate ligament, donor2	10295-104G7	22.69	13.78	4.86	0.00
diaphragm, fetal, donor1	10069-101I6	18.46	38.52	0.00	0.00
diencephalon, adult	10193-103E4	13.92	25.44	0.96	0.96
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	24.11	39.95	1.61	0.46
ductal cell carcinoma cell line:KLM-1	10438-106E6	63.08	35.90	2.82	0.77
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	70.53	17.09	4.33	0.24
ductus deferens, adult	10196-103E7	14.45	28.90	0.50	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	15.84	27.36	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	22.81	36.05	0.74	0.74
dura mater, adult, donor1	10041-101F5	19.66	29.48	0.41	0.83
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	59.29	15.99	3.33	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	100.16	20.06	8.02	0.57
embryonic pancreas cell line:1B2C6	10604-108F1	38.23	20.35	1.85	0.62
embryonic pancreas cell line:1C3D3	10605-108F2	49.34	26.64	2.42	0.30
embryonic pancreas cell line:1C3IKEI	10606-108F3	37.05	29.95	2.16	0.31
embryonic pancreas cell line:2C6	10603-108E9	26.27	27.58	1.31	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	40.22	33.52	2.35	0.67
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	99.68	90.44	7.97	1.63
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	25.57	25.89	1.77	0.48
epidermoid carcinoma cell line:A431	10426-106D3	101.71	36.13	8.78	1.89
epidermoid carcinoma cell line:Ca Ski	10431-106D8	105.48	39.81	4.40	1.10
epididymis, adult	10197-103E8	9.42	14.65	0.00	0.42
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	32.82	24.48	3.19	0.35
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	9.83	16.12	1.57	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	28.83	24.77	2.10	0.26
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	29.23	25.98	1.87	0.20
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	31.93	23.41	1.90	0.22
esophagus, adult, pool1	10015-101C6	24.42	22.93	1.70	0.64
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	38.82	40.45	3.26	0.63
eye - muscle inferior rectus, donor1	10272-104E2	12.07	7.24	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	27.35	29.46	2.10	0.00
eye - muscle medial, donor2	10299-104H2	1.49	13.39	0.00	0.00
eye - muscle superior, donor2	10297-104G9	16.05	8.03	1.15	0.00
eye - vitreous humor, donor1	10268-104D7	23.32	14.57	1.46	1.46
eye, fetal, donor1	10054-101G9	11.69	27.97	1.02	1.02
fibrosarcoma cell line:HT-1080	10758-110E2	72.83	33.98	6.80	1.03
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	87.13	23.50	9.97	0.47
frontal lobe, adult, pool1	10040-101F4	23.46	48.13	1.97	2.06
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	49.54	43.84	2.40	0.60
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	72.05	38.77	6.03	0.46
gall bladder, adult	10198-103E9	12.80	14.49	1.45	0.24
gamma delta positive T cells, donor1	11937-126A2	11.27	28.45	0.54	0.00
gamma delta positive T cells, donor2	11938-126A3	12.70	29.51	0.37	0.75
gastric adenocarcinoma cell line:MKN1	10614-108G2	47.95	29.36	2.96	2.11
gastric adenocarcinoma cell line:MKN45	10612-108F9	23.40	18.18	1.74	0.58
gastric cancer cell line:AZ521	10549-107H9	92.80	55.09	7.54	1.64
gastric cancer cell line:GSS	10560-108A2	118.06	40.27	11.90	1.83
gastrointestinal carcinoma cell line:ECC12	10615-108G3	27.87	47.52	2.28	2.06
giant cell carcinoma cell line:LU65	10487-107B1	105.45	47.27	4.59	0.11
giant cell carcinoma cell line:Lu99B	10433-106E1	106.93	28.97	6.72	0.28
glassy cell carcinoma cell line:HOKUG	10688-109F4	11.97	11.97	0.75	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	23.12	39.16	1.27	0.32
glioblastoma cell line:A172, tech_rep2	10444-106F3	23.59	39.18	0.98	0.56
glioblastoma cell line:T98G	10485-107A8	70.97	55.08	6.07	0.88
glioma cell line:GI-1	10413-106B8	36.61	29.58	3.22	0.29
globus pallidus - adult, donor10196	10175-103C4	21.87	22.60	0.73	0.00
globus pallidus, adult, donor10252	10161-103A8	20.26	42.47	2.69	2.44
globus pallidus, adult, donor10258	10367-105F7	6.85	13.69	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	19.19	26.65	1.60	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	24.47	29.37	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	43.71	10.93	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	15.68	5.23	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	21.12	15.36	0.96	0.96
hIPS +CCl2, biol_rep1	14383-156B9	76.21	17.91	1.84	0.92
hIPS +CCl2, biol_rep2	14384-156C1	58.53	14.63	4.12	0.91
hIPS +CCl2, biol_rep3	14385-156C2	65.05	11.59	5.15	1.93
hIPS, biol_rep1	14380-156B6	67.55	18.68	1.44	0.00
hIPS, biol_rep2	14381-156B7	56.93	19.20	2.74	0.00
hIPS, biol_rep3	14382-156B8	33.10	18.76	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	52.58	25.00	4.88	0.00
heart - mitral valve, adult	10205-103F7	10.16	19.73	0.00	0.30
heart - pulmonic valve, adult	10206-103F8	12.03	29.29	1.31	1.05
heart - tricuspid valve, adult	10207-103F9	9.99	32.47	0.83	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	23.06	21.63	2.45	0.20
heart, adult, diseased, donor1	10051-101G6	26.83	32.79	2.55	0.43
heart, adult, pool1	10016-101C7	26.45	24.61	2.30	0.69
heart, fetal, pool1	10046-101G1	25.67	58.84	1.85	2.16
hepatic mesenchymal tumor cell line:LI90	10778-110G4	22.52	16.35	1.85	0.93
hepatoblastoma cell line:HuH-6	10633-108I3	63.03	13.08	2.38	1.19
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	71.93	80.66	5.97	2.76
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	77.32	76.10	6.80	2.31
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	74.98	83.07	4.45	2.02
hepatoma cell line:Li-7	10484-107A7	35.59	30.03	1.45	0.22
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	55.28	29.35	3.72	1.21
hippocampus - adult, donor10196	10169-103B7	15.14	29.34	2.84	1.89
hippocampus, adult, donor10252	10153-102I9	16.74	44.70	2.25	1.63
hippocampus, adult, donor10258	10374-105G5	9.46	25.89	1.00	1.00
hippocampus, newborn, donor10223	10363-105F3	16.92	25.38	1.41	0.70
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	109.25	48.83	15.87	0.61
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	82.67	21.99	8.05	0.59
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	89.88	22.34	7.87	0.25
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	64.84	8.46	6.77	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	64.29	11.36	12.65	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	67.57	12.53	6.45	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	44.38	14.01	5.26	0.88
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	40.93	16.37	7.32	0.65
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	35.03	13.35	5.42	0.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	35.99	24.15	4.26	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	34.55	23.63	4.50	0.96
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	36.36	24.24	9.43	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	66.35	24.41	7.20	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	76.64	29.48	5.40	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	92.51	40.15	2.62	1.75
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	70.26	13.75	9.16	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	61.92	15.70	5.67	1.31
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	51.48	12.49	6.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	47.66	10.74	7.35	0.57
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	50.93	13.64	6.37	0.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	39.47	10.02	8.77	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	13.39	14.86	1.80	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	13.64	14.23	1.74	0.29
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	17.04	9.27	2.09	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	80.92	25.86	10.16	0.18
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	82.45	21.97	5.42	0.86
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	91.46	25.72	10.21	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	42.25	19.01	5.99	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	43.08	11.40	5.38	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	48.72	8.78	6.05	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	27.92	8.27	4.65	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	37.86	7.31	2.66	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	22.57	8.47	1.54	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	16.62	13.80	1.79	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	29.53	15.90	3.79	2.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	17.81	12.43	0.34	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	75.59	20.05	10.14	0.48
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	91.36	23.17	10.25	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	77.07	21.46	5.85	0.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	63.57	11.92	6.72	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	224.47	110.61	26.03	3.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	66.85	16.55	8.94	0.33
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	42.69	9.85	3.83	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	38.72	7.60	3.62	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	32.74	7.47	3.56	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	21.48	17.90	3.58	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	32.91	20.45	3.11	0.41
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	26.13	11.58	4.31	0.27
immature langerhans cells, donor1	11904-125F5	5.57	15.74	0.24	0.73
immature langerhans cells, donor2	11905-125F6	3.17	12.67	0.79	0.00
insula, adult, pool1	10039-101F3	29.90	56.59	2.18	1.51
keratoacanthoma cell line:HKA-1	10791-110H8	12.03	22.44	0.65	0.98
kidney, adult, pool1	10017-101C8	17.82	32.64	1.00	1.50
kidney, fetal, pool1	10045-101F9	19.31	44.00	1.06	1.70
large cell lung carcinoma cell line:IA-LM	10509-107D5	32.66	46.01	1.99	1.42
large cell lung carcinoma cell line:NCI-H460	10839-111E2	4.84	9.82	0.83	0.14
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	31.01	17.62	1.28	0.55
left atrium, adult, donor1	10079-102A7	13.08	27.79	0.00	1.09
left ventricle, adult, donor1	10078-102A6	11.12	21.74	2.02	0.51
leiomyoblastoma cell line:G-402	10721-110A1	45.42	24.62	4.10	0.27
leiomyoma cell line:10964C	10569-108B2	13.29	8.62	1.44	0.36
leiomyoma cell line:15242A	10570-108B3	19.57	13.04	1.63	0.00
leiomyoma cell line:15425	10571-108B4	20.15	12.87	1.46	0.24
leiomyosarcoma cell line:Hs 5.T	10722-110A2	6.35	6.35	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	34.50	18.82	2.09	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	71.78	44.98	5.67	2.95
liposarcoma cell line:KMLS-1	10782-110G8	15.00	15.93	1.41	0.31
liposarcoma cell line:SW 872	10726-110A6	28.75	29.12	2.19	1.22
liver, adult, pool1	10018-101C9	17.34	19.77	0.32	0.49
liver, fetal, pool1	10086-102B5	19.75	16.93	0.00	2.82
locus coeruleus - adult, donor10196	10182-103D2	18.81	24.79	1.90	0.44
locus coeruleus, adult, donor10252	10165-103B3	18.09	34.33	1.11	0.37
locus coeruleus, adult, donor10258	10375-105G6	16.08	23.14	3.67	0.28
locus coeruleus, newborn, donor10223	10362-105F2	15.56	37.86	0.42	0.00
lung adenocarcinoma cell line:A549	10499-107C4	43.87	27.54	3.04	0.69
lung adenocarcinoma cell line:PC-14	10408-106B3	37.92	35.85	2.07	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	13.05	9.62	0.79	0.13
lung, adult, pool1	10019-101D1	20.91	18.19	1.06	0.47
lung, fetal, donor1	10068-101I5	26.83	53.09	1.71	2.00
lung, right lower lobe, adult, donor1	10075-102A3	10.54	17.87	0.46	0.46
lymph node, adult, donor1	10077-102A5	11.36	19.88	0.95	0.47
lymphangiectasia cell line:DS-1	10727-110A7	28.93	23.89	2.41	0.44
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	22.64	44.22	0.45	1.06
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	45.02	34.83	2.55	0.00
mature adipocyte, donor1	12231-129F8	10.66	14.65	0.44	0.89
mature adipocyte, donor2	12232-129F9	10.79	23.87	0.62	1.25
mature adipocyte, donor3	12233-129G1	13.75	23.23	0.24	1.19
mature adipocyte, donor4	12234-129G2	23.69	33.43	1.84	1.32
maxillary sinus tumor cell line:HSQ-89	10414-106B9	86.49	65.04	6.67	1.19
medial frontal gyrus - adult, donor10196	10170-103B8	25.94	29.33	1.13	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	18.57	43.40	0.55	2.57
medial frontal gyrus, adult, donor10258	10368-105F8	18.43	26.69	0.64	0.64
medial frontal gyrus, newborn, donor10223	10352-105E1	26.02	52.88	4.26	1.71
medial temporal gyrus - adult, donor10196	10183-103D3	25.99	43.37	2.19	1.69
medial temporal gyrus, adult, donor10252	10156-103A3	18.89	45.84	1.06	1.49
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	13.48	26.97	1.93	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	172.24	0.00	14.35
medial temporal gyrus, newborn, donor10223	10353-105E2	30.51	23.69	2.51	0.00
medulla oblongata - adult, donor10196	10174-103C3	13.63	23.36	0.65	0.00
medulla oblongata, adult, donor10252	10155-103A2	16.87	36.84	1.08	0.77
medulla oblongata, adult, pool1	10038-101F2	21.14	41.71	1.96	0.73
medulla oblongata, newborn, donor10223	10361-105F1	15.28	24.30	0.69	0.00
medulloblastoma cell line:D283 Med	10838-111E1	56.46	70.63	6.42	1.55
medulloblastoma cell line:ONS-76	10759-110E3	89.63	40.47	9.42	0.98
melanoma cell line:COLO 679	10514-107E1	31.19	32.77	1.44	1.44
melanoma cell line:G-361	10465-106H6	55.65	40.18	3.26	0.27
meningioma cell line:HKBMM	10691-109F7	24.96	18.27	1.99	0.18
merkel cell carcinoma cell line:MKL-1	10843-111E6	35.25	54.63	3.52	4.41
merkel cell carcinoma cell line:MS-1	10844-111E7	73.36	39.40	5.70	0.52
mesenchymal precursor cell - adipose, donor1	11747-123G1	24.55	24.09	1.38	0.92
mesenchymal precursor cell - adipose, donor2	11748-123G2	14.72	14.00	0.18	0.55
mesenchymal precursor cell - adipose, donor3	11749-123G3	22.78	13.25	1.24	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	12.36	15.03	0.56	0.42
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	8.28	14.64	0.19	0.77
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	12.49	20.82	0.69	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	32.27	24.03	1.20	0.51
mesenchymal precursor cell - cardiac, donor2	11753-123G7	17.60	16.79	1.15	0.23
mesenchymal precursor cell - cardiac, donor3	11754-123G8	22.68	21.09	1.46	0.93
mesenchymal precursor cell - cardiac, donor4	11755-123G9	25.39	23.90	0.54	0.68
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	36.56	20.34	2.28	1.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	18.44	17.13	1.32	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	20.06	21.45	1.66	0.83
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	24.09	15.01	0.70	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	22.05	17.15	0.82	0.61
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	17.97	16.18	0.36	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	11.48	15.72	0.31	0.93
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	21.20	12.77	0.91	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	40.70	34.40	1.68	1.26
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	16.59	17.93	1.05	0.30
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	24.42	21.88	1.84	0.96
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	18.78	20.25	0.74	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	15.74	14.59	1.43	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	23.58	20.63	4.21	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	11.87	9.59	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	10.74	13.30	1.28	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	12.83	12.30	1.31	0.52
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	11.71	13.56	1.85	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	8.47	13.42	0.71	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	19.29	12.52	0.68	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	16.90	9.04	1.57	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	13.90	11.12	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	48.30	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	13.27	15.86	0.87	0.87
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	9.37	14.28	1.56	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	12.98	11.30	1.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	8.80	16.87	0.73	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	7.72	11.08	1.34	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	10.23	14.74	0.82	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	10.74	15.89	0.00	1.29
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	24.61	16.41	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	0.00	15.49	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	13.32	11.69	1.30	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	11.64	11.64	2.91	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	14.93	11.73	0.53	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	9.81	9.81	2.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	15.94	11.27	1.55	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	10.49	8.39	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	10.93	7.95	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	0.00	4.77	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	9.49	9.49	0.59	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	14.62	9.75	1.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	15.20	10.13	1.90	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	12.76	7.59	1.38	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	4.30	15.04	2.15	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	19.96	11.98	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	17.22	6.89	3.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	8.96	11.00	0.00	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	8.74	11.92	0.79	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	5.31	10.61	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	4.99	9.97	0.62	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	4.01	4.01	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	14.19	14.19	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	0.00	5.14	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	10.33	15.83	1.38	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	14.35	14.35	0.49	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	16.82	8.97	2.24	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	13.99	15.27	0.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	14.91	17.73	0.40	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	13.08	17.44	0.00	2.18
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	21.54	8.87	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	7.28	16.39	0.61	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	9.04	18.08	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	14.00	16.47	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	12.90	14.09	0.79	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	8.76	13.30	0.32	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	5.09	12.22	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	12.38	20.12	0.77	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	97.10	45.12	7.32	0.24
mesothelioma cell line:ACC-MESO-4	10494-107B8	48.19	35.91	3.01	0.46
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	21.37	17.09	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	45.21	36.37	1.64	1.23
mesothelioma cell line:Mero-25	10850-111F4	26.33	21.56	1.59	0.45
mesothelioma cell line:Mero-41	10851-111F5	45.23	30.07	3.18	0.73
mesothelioma cell line:Mero-48a	10852-111F6	19.49	18.38	1.77	0.22
mesothelioma cell line:Mero-82	10853-111F7	27.86	28.65	1.58	0.53
mesothelioma cell line:Mero-83	10854-111F8	35.41	19.92	2.04	0.34
mesothelioma cell line:Mero-84	10855-111F9	29.07	24.77	1.26	0.51
mesothelioma cell line:Mero-95	10856-111G1	27.74	22.57	1.45	0.83
mesothelioma cell line:NCI-H2052	10847-111F1	45.88	28.49	3.31	0.17
mesothelioma cell line:NCI-H226	10846-111E9	19.73	8.33	1.09	0.72
mesothelioma cell line:NCI-H2452	10848-111F2	24.77	23.40	3.42	0.51
mesothelioma cell line:NCI-H28	10845-111E8	28.50	31.55	2.29	0.25
mesothelioma cell line:No36	10857-111G2	45.02	29.36	2.28	0.33
mesothelioma cell line:ONE58	10858-111G3	17.88	12.19	1.35	0.54
migratory langerhans cells, donor1	11901-125F2	18.81	24.37	0.96	1.15
migratory langerhans cells, donor2	11902-125F3	16.61	30.77	1.47	1.10
migratory langerhans cells, donor3	11903-125F4	21.00	37.51	0.90	1.62
mixed mullerian tumor cell line:HTMMT	10689-109F5	54.20	32.65	2.94	0.33
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	33.06	15.26	4.24	0.64
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	93.06	38.24	7.14	1.38
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	19.60	19.03	1.14	0.57
myelodysplastic syndrome cell line:SKM-1	10772-110F7	70.78	64.68	4.80	0.55
myeloma cell line:PCM6	10474-106I6	27.08	36.17	1.58	1.38
myxofibrosarcoma cell line:MFH-ino	10600-108E6	48.19	17.76	2.03	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	34.13	25.69	1.96	0.39
nasal epithelial cells, donor1, tech_rep1	12226-129F3	131.37	34.32	8.02	0.67
nasal epithelial cells, donor1, tech_rep2	12226-129F3	130.83	32.43	10.74	0.66
nasal epithelial cells, donor2	12227-129F4	97.70	34.78	5.52	1.10
neuroblastoma cell line:CHP-134	10508-107D4	27.38	32.67	2.30	0.92
neuroblastoma cell line:NB-1	10539-107G8	73.15	60.99	4.49	1.12
neuroblastoma cell line:NBsusSR	10607-108F4	44.08	55.89	3.37	1.48
neuroblastoma cell line:NH-12	10555-107I6	46.59	53.11	3.17	1.30
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	22.77	39.85	0.71	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	29.93	37.38	2.38	1.43
neuroectodermal tumor cell line:TASK1	10774-110F9	31.40	17.71	2.01	0.60
neuroepithelioma cell line:SK-N-MC	10728-110A8	55.95	27.97	8.90	1.27
neurofibroma cell line:Hs 53.T	10729-110A9	23.95	14.64	2.66	0.27
neutrophil PMN, donor1	12133-128D9	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	13.28	0.00	0.00
neutrophil PMN, donor3	12141-128E8	28.41	9.47	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	75.09	89.13	4.90	3.38
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	44.83	39.22	2.40	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	13.14	12.50	0.32	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	12.88	17.08	2.10	0.26
nucleus accumbens, adult, pool1	10037-101F1	29.43	48.65	2.62	1.69
occipital cortex - adult, donor10196	10172-103C1	45.33	35.03	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	17.71	46.16	0.81	1.34
occipital cortex, newborn, donor10223	10355-105E4	28.75	33.48	3.28	0.00
occipital lobe, adult, donor1	10076-102A4	22.04	24.14	2.10	1.57
occipital lobe, fetal, donor1	10073-102A1	42.48	72.09	3.43	2.15
occipital pole, adult, pool1	10036-101E9	22.39	37.13	1.50	1.50
olfactory region, adult	10195-103E6	13.37	34.20	0.96	0.76
optic nerve, donor1	10277-104E7	14.01	14.01	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	38.27	31.21	2.51	0.80
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	153.87	28.30	12.23	0.27
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	28.11	18.63	2.71	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	36.96	33.50	2.77	2.89
osteoclastoma cell line:Hs 706.T	10704-109H2	14.70	14.40	0.59	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	49.52	14.02	3.74	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	34.78	36.90	1.27	0.85
ovary, adult, pool1	10020-101D2	15.64	33.19	0.87	0.96
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	67.46	24.20	7.88	1.28
pancreas, adult, donor1	10049-101G4	26.34	24.46	0.94	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	18.73	31.31	0.84	0.56
papillary adenocarcinoma cell line:8505C	10437-106E5	60.31	57.07	3.07	0.34
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	28.98	38.08	1.16	0.99
paracentral gyrus, adult, pool1	10035-101E8	27.82	44.11	1.10	2.01
parietal cortex, adult, donor10258	10373-105G4	17.62	25.69	1.47	1.47
parietal lobe - adult, donor10196	10171-103B9	14.11	22.57	1.88	0.00
parietal lobe, adult, donor10252	10157-103A4	17.39	39.91	0.86	1.43
parietal lobe, adult, pool1	10034-101E7	23.88	42.56	1.59	2.29
parietal lobe, fetal, donor1	10072-101I9	41.70	81.47	2.91	0.97
parietal lobe, newborn, donor10223	10356-105E5	26.92	34.77	4.11	0.37
parotid gland, adult	10199-103F1	14.80	26.52	0.62	0.00
penis, adult	10200-103F2	10.74	27.93	1.07	1.07
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	80.32	44.07	5.95	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	20.83	15.88	1.60	0.29
pineal gland - adult, donor10196	10179-103C8	7.74	27.09	0.00	0.65
pineal gland, adult, donor10252	10160-103A7	21.91	79.95	1.78	1.18
pineal gland, adult, donor10258	10377-105G8	8.15	26.34	0.00	1.25
pituitary gland - adult, donor10196	10180-103C9	13.15	43.51	1.01	0.00
pituitary gland, adult, donor10252	10162-103A9	24.50	76.61	1.04	2.61
pituitary gland, adult, donor10258	10378-105G9	17.88	38.31	0.85	0.85
placenta, adult, pool1	10021-101D3	10.11	24.94	0.32	1.08
plasma cell leukemia cell line:ARH-77	10840-111E3	41.45	29.40	2.52	0.66
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	25.21	37.82	0.31	1.56
pons, adult, pool1	10033-101E6	26.51	38.90	1.46	1.12
postcentral gyrus, adult, pool1	10032-101E5	20.40	44.63	1.74	1.74
promyelocytes/myelocytes PMC, donor1	12132-128D8	12.55	12.55	2.09	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	16.52	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	11.74	11.74	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	80.55	24.03	5.83	0.00
prostate cancer cell line:PC-3	10439-106E7	95.47	60.80	5.99	1.63
prostate, adult, pool1	10022-101D4	10.34	24.94	0.36	0.45
putamen, adult, donor10196	10176-103C5	25.73	52.17	0.94	2.12
putamen, adult, donor10252	10152-102I8	25.49	27.45	1.96	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	30.60	14.21	2.19	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	17.64	21.50	0.48	0.48
putamen, newborn, donor10223	10365-105F5	24.74	70.47	0.75	1.50
rectal cancer cell line:TT1TKB	10469-106I1	54.70	34.33	2.62	0.58
rectum, fetal, donor1	10067-101I4	23.65	30.60	1.39	2.78
renal cell carcinoma cell line:OS-RC-2	10411-106B6	101.34	40.49	9.12	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	123.02	33.55	3.73	0.00
retina, adult, pool1	10030-101E3	13.82	37.47	0.60	1.29
retinoblastoma cell line:Y79	10475-106I7	73.00	47.02	4.16	2.08
rhabdomyosarcoma cell line:KYM-1	10787-110H4	60.49	22.01	7.50	0.86
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	61.02	39.93	4.50	0.84
sacrococcigeal teratoma cell line:HTST	10695-109G2	15.16	10.61	0.76	0.76
salivary acinar cells, donor1	11771-123I7	14.08	20.39	0.32	0.32
salivary acinar cells, donor2	11772-123I8	11.43	18.73	0.83	0.28
salivary acinar cells, donor3	11773-123I9	8.61	11.25	0.66	1.32
salivary gland, adult, pool1	10093-102C3	15.44	37.18	0.57	1.72
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	25.80	18.04	2.19	0.17
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	25.51	17.52	1.41	0.35
seminal vesicle, adult	10201-103F3	16.93	13.23	3.17	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	16.76	25.75	0.97	0.73
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	20.38	22.14	1.26	1.26
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	31.11	20.07	2.01	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	49.70	23.77	3.90	0.67
signet ring carcinoma cell line:Kato III	10436-106E4	68.42	44.98	2.87	0.99
signet ring carcinoma cell line:NUGC-4	10483-107A6	28.00	30.84	0.52	1.03
skeletal muscle - soleus muscle, donor1	10282-104F3	37.59	27.66	3.55	0.00
skeletal muscle, adult, pool1	10023-101D5	40.42	43.42	2.76	1.44
skeletal muscle, fetal, donor1	10066-101I3	20.10	51.26	0.00	0.00
skin, adult, donor1	10074-102A2	13.57	27.14	0.00	0.00
skin, fetal, donor1	10065-101I2	17.67	26.51	0.00	1.26
small cell cervical cancer cell line:HCSC-1	10800-110I8	70.37	45.03	8.00	1.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	32.78	70.92	2.52	1.89
small cell lung carcinoma cell line:DMS 144	10841-111E4	98.49	38.36	11.18	0.19
small cell lung carcinoma cell line:LK-2	10541-107H1	75.16	53.40	2.64	0.66
small cell lung carcinoma cell line:NCI-H82	10842-111E5	203.64	25.41	24.93	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	18.09	34.43	2.18	1.96
small intestine, adult, pool1	10024-101D6	20.90	37.39	0.24	1.19
small intestine, fetal, donor1	10064-101I1	14.25	34.15	1.23	0.25
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	34.36	17.95	2.05	1.03
smooth muscle, adult, pool1	10048-101G3	14.22	22.49	0.78	0.78
somatostatinoma cell line:QGP-1	10781-110G7	33.23	34.31	1.61	1.61
spinal cord - adult, donor10196	10181-103D1	12.62	28.91	1.15	0.00
spinal cord, adult, donor10252	10159-103A6	18.92	39.03	1.18	0.39
spinal cord, adult, donor10258	10369-105F9	4.15	26.98	1.38	0.69
spinal cord, fetal, donor1	10056-101H2	20.73	43.91	2.44	1.22
spinal cord, newborn, donor10223	10359-105E8	15.15	27.55	1.38	0.92
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	28.97	16.73	1.94	0.60
spleen, adult, pool1	10025-101D7	12.78	30.29	0.66	0.55
spleen, fetal, pool1	10044-101F8	15.57	29.80	1.11	1.51
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	40.27	34.26	3.11	0.93
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	40.63	21.27	1.14	0.19
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	28.66	23.41	2.80	0.70
squamous cell carcinoma cell line:T3M-5	10616-108G4	150.51	38.70	9.77	0.78
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	110.53	85.32	5.85	1.58
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	22.45	20.33	4.66	1.69
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	27.92	23.69	0.85	0.00
stomach, fetal, donor1	10062-101H8	25.63	17.09	0.00	1.07
submaxillary gland, adult	10202-103F4	10.82	15.38	0.57	0.00
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	16.82	36.97	1.66	0.42
substantia nigra, adult, donor10258	10371-105G2	11.90	16.03	0.00	0.52
substantia nigra, newborn, donor10223	10358-105E7	24.73	20.49	1.41	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	49.29	52.96	4.36	1.60
temporal lobe, adult, pool1	10031-101E4	20.60	37.30	1.70	1.70
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	34.90	59.83	3.56	5.70
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	31.65	61.10	2.20	0.44
tenocyte, donor1	11763-123H8	12.92	16.76	0.35	0.00
tenocyte, donor2	11765-123I1	6.49	14.88	0.76	0.00
tenocyte, donor3	11768-123I4	10.01	14.09	1.85	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	65.09	29.57	5.44	0.68
teratocarcinoma cell line:NCR-G1	10798-110I6	67.98	37.15	6.47	2.00
teratocarcinoma cell line:PA-1	10807-111A6	118.25	17.98	13.17	0.77
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	24.12	9.77	2.29	0.38
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	102.48	69.58	9.83	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	52.24	27.48	1.85	1.20
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	88.92	47.88	5.54	0.33
testis, adult, pool1	10026-101D8	49.82	61.74	2.25	1.83
testis, adult, pool2	10096-102C6	103.75	64.51	7.67	1.35
thalamus - adult, donor10196	10168-103B6	22.08	35.33	1.10	0.00
thalamus, adult, donor10252	10154-103A1	17.82	45.17	0.94	1.25
thalamus, adult, donor10258, tech_rep1	10370-105G1	18.48	24.63	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	14.33	17.29	1.48	0.66
thalamus, newborn, donor10223	10366-105F6	29.92	31.64	4.60	0.00
throat, adult	10209-103G2	18.48	15.98	0.25	0.25
throat, fetal, donor1	10061-101H7	14.93	31.99	0.91	1.83
thymic carcinoma cell line:Ty-82	10803-111A2	39.55	37.16	1.99	1.99
thymus, adult, pool1	10027-101D9	19.29	47.12	0.99	1.19
thymus, fetal, pool1	10043-101F7	24.42	44.06	0.94	2.18
thyroid carcinoma cell line:KHM-5M	10776-110G2	86.03	44.41	6.91	0.66
thyroid carcinoma cell line:TCO-1	10783-110G9	119.44	44.28	10.34	0.56
thyroid, adult, pool1	10028-101E1	14.46	28.18	0.47	1.68
thyroid, fetal, donor1	10060-101H6	9.49	27.16	1.32	1.32
tongue epidermis (fungiform papillae), donor1	10288-104F9	6.16	15.40	0.00	0.00
tongue, adult	10203-103F5	19.30	20.93	1.40	0.00
tongue, fetal, donor1	10059-101H5	16.95	44.14	0.79	1.58
tonsil, adult, pool1	10047-101G2	24.04	37.67	0.90	0.90
trachea, adult, pool1	10029-101E2	16.77	25.03	1.15	0.98
trachea, fetal, donor1	10058-101H4	16.54	32.31	0.38	1.15
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	24.45	18.42	2.48	0.71
transitional-cell carcinoma cell line:5637	10418-106C4	72.24	48.23	4.86	1.22
transitional-cell carcinoma cell line:JMSU1	10492-107B6	49.67	26.64	3.60	0.16
tridermal teratoma cell line:HGRT	10694-109G1	38.05	11.42	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	8.63	13.88	0.68	0.17
umbilical cord, fetal, donor1	10057-101H3	20.87	27.12	2.09	2.09
uterus, adult, pool1	10100-102D1	13.48	39.93	0.51	1.19
uterus, fetal, donor1	10055-101H1	18.94	33.79	1.02	0.00
vagina, adult	10204-103F6	20.03	17.45	0.00	0.00
vein, adult	10191-103E2	12.93	19.73	1.10	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	20.29	17.62	2.14	0.53